Details of the Drug Combinations

General Information of This Drug (ID: DMWTAOI)

Drug Name
Estramustine   DMWTAOI
Synonyms
Estramustina; Estramustinum; Emcyt (TN); Estramustine (USAN/INN); Estradiol 3-[bis(2-chloroethyl)carbamate]; Ro-22-2296/000; Estra-1,3,5(10)-triene-3,17-diol (17.beta.)-, 3-[bis(2-chloroethyl)carbamate]; [(8R,9S,13S,14S,17S)-17-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-yl] N,N-bis(2-chloroethyl)carbamate; (17beta)-17-hydroxyestra-1(10),2,4-trien-3-yl bis(2-chloroethyl)carbamate; 17.beta.-Estradiol 3-[bis(2-chloroethyl)carbamate]
Indication
Disease Entry ICD 11 Status REF
Prostate cancer 2C82.0 Approved [1]
Therapeutic Class
Anticancer Agents
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL

List of Combinatorial Drugs (CBD) Containing This Drug

858 Investigative Drug Combination(s) Consisting of This drug
Normalized Drug Combination Synergy Score
Synergy scores were normalized using Min-Max Scaling to facilitate visual comparisons.
DrugCom Name DrugCom ID Component Drug Indication REF
ABIRATERONE + Estramustine DCKIFIE ABIRATERONE Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [2]
ABIRATERONE + Estramustine DCRIEW8 ABIRATERONE Clear cell renal cell carcinoma (Cell Line: 786-0) [2]
ABIRATERONE + Estramustine DCJJWHU ABIRATERONE Renal cell carcinoma (Cell Line: UO-31) [2]
ABIRATERONE + Estramustine DCVL7Z6 ABIRATERONE Breast adenocarcinoma (Cell Line: MDA-MB-468) [3]
ABIRATERONE + Estramustine DCF770Q ABIRATERONE Carcinoma (Cell Line: RXF 393) [3]
ABIRATERONE + Estramustine DCSHYT9 ABIRATERONE Colon adenocarcinoma (Cell Line: COLO 205) [3]
ABIRATERONE + Estramustine DCE28KY ABIRATERONE Adenocarcinoma (Cell Line: DU-145) [4]
ABIRATERONE + Estramustine DCAYMWR ABIRATERONE High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [4]
ABIRATERONE + Estramustine DC6H2XZ ABIRATERONE Large cell lung carcinoma (Cell Line: NCI-H460) [4]
ABIRATERONE + Estramustine DCNDTJL ABIRATERONE Malignant melanoma (Cell Line: LOX IMVI) [4]
Acamprosate + Estramustine DCP5GE9 Acamprosate Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Albendazole + Estramustine DCX95CD Albendazole Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Allopurinol + Estramustine DCT79HP Allopurinol Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Amonafide + Estramustine DC3WADT Amonafide Adenocarcinoma (Cell Line: NCIH23) [2]
Amonafide + Estramustine DCTNH1N Amonafide Adenocarcinoma (Cell Line: HCT-15) [2]
Amonafide + Estramustine DC8XHPU Amonafide Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [2]
Amonafide + Estramustine DCP4Z6G Amonafide Astrocytoma (Cell Line: U251) [2]
Amonafide + Estramustine DCEWGCP Amonafide Clear cell renal cell carcinoma (Cell Line: 786-0) [2]
Amonafide + Estramustine DC0WFRX Amonafide Glioma (Cell Line: SF-268) [2]
Amonafide + Estramustine DCR2VU7 Amonafide Non-small cell lung carcinoma (Cell Line: HOP-92) [2]
Anastrozole + Estramustine DCO9RPD Anastrozole Adenocarcinoma (Cell Line: DU-145) [2]
Anastrozole + Estramustine DCPEYB2 Anastrozole Adenocarcinoma (Cell Line: HT29) [2]
Anastrozole + Estramustine DC36V36 Anastrozole Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [2]
Anastrozole + Estramustine DCU5RSH Anastrozole Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [2]
Anastrozole + Estramustine DC76UBD Anastrozole Glioblastoma (Cell Line: SNB-75) [2]
Anastrozole + Estramustine DCLTAJ9 Anastrozole Lung adenocarcinoma (Cell Line: NCI-H522) [2]
Anastrozole + Estramustine DCCN5GI Anastrozole Melanoma (Cell Line: UACC-257) [2]
Anastrozole + Estramustine DCWBHKI Anastrozole Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [2]
Aprepitant + Estramustine DC55GK6 Aprepitant Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Arfolitixorin + Estramustine DCBLXEK Arfolitixorin Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [2]
Artemisinin + Estramustine DCIFKV6 Artemisinin Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Azatadine + Estramustine DCT87WW Azatadine Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
BIO-300 + Estramustine DC1F7Q2 BIO-300 Clear cell renal cell carcinoma (Cell Line: 786-0) [2]
BIO-300 + Estramustine DCARMUM BIO-300 Glioma (Cell Line: SF-268) [2]
BIO-300 + Estramustine DCW0C82 BIO-300 Adenocarcinoma (Cell Line: OVCAR3) [4]
BIO-300 + Estramustine DCVKUMI BIO-300 Amelanotic melanoma (Cell Line: M14) [4]
Bortezomib + Estramustine DC220WM Bortezomib Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Brincidofovir + Estramustine DCG4545 Brincidofovir Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Cabazitaxel + Estramustine DC1AXBJ Cabazitaxel Adenocarcinoma (Cell Line: DU-145) [2]
Cabazitaxel + Estramustine DCBAZBE Cabazitaxel Adenocarcinoma (Cell Line: A549) [2]
Cabazitaxel + Estramustine DC4EB3E Cabazitaxel Adenocarcinoma (Cell Line: HT29) [2]
Cabazitaxel + Estramustine DC4IPS9 Cabazitaxel Adenocarcinoma (Cell Line: HCT116) [2]
Cabazitaxel + Estramustine DCCZXCR Cabazitaxel Adenocarcinoma (Cell Line: HCT-15) [2]
Cabazitaxel + Estramustine DC3YZ3T Cabazitaxel Adenocarcinoma (Cell Line: HCC-2998) [2]
Cabazitaxel + Estramustine DC86NJ2 Cabazitaxel Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [2]
Cabazitaxel + Estramustine DCUT1KH Cabazitaxel Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [2]
Cabazitaxel + Estramustine DCF9765 Cabazitaxel Anaplastic large cell lymphoma (Cell Line: SR) [2]
Cabazitaxel + Estramustine DC6DV3I Cabazitaxel Astrocytoma (Cell Line: U251) [2]
Cabazitaxel + Estramustine DCNZNXL Cabazitaxel Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [2]
Cabazitaxel + Estramustine DCO913O Cabazitaxel Clear cell renal cell carcinoma (Cell Line: A498) [2]
Cabazitaxel + Estramustine DCW4JX3 Cabazitaxel Clear cell renal cell carcinoma (Cell Line: 786-0) [2]
Cabazitaxel + Estramustine DCVKE8S Cabazitaxel Cutaneous melanoma (Cell Line: SK-MEL-5) [2]
Cabazitaxel + Estramustine DCQBVFJ Cabazitaxel Glioma (Cell Line: SF-539) [2]
Cabazitaxel + Estramustine DCNP2JC Cabazitaxel Glioma (Cell Line: SF-295) [2]
Cabazitaxel + Estramustine DCWAMGC Cabazitaxel Large cell lung carcinoma (Cell Line: NCI-H460) [2]
Cabazitaxel + Estramustine DCWDWAO Cabazitaxel Lung adenocarcinoma (Cell Line: MDA-MB-231) [2]
Cabazitaxel + Estramustine DCCETUR Cabazitaxel Lung adenocarcinoma (Cell Line: NCI-H522) [2]
Cabazitaxel + Estramustine DCW7XPF Cabazitaxel Malignant melanoma (Cell Line: UACC62) [2]
Cabazitaxel + Estramustine DCPSGGQ Cabazitaxel Melanoma (Cell Line: UACC-257) [2]
Cabazitaxel + Estramustine DCU9C20 Cabazitaxel Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [2]
Cabazitaxel + Estramustine DCS45O5 Cabazitaxel Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [2]
Cabazitaxel + Estramustine DCLL8BU Cabazitaxel Papillary renal cell carcinoma (Cell Line: ACHN) [2]
Cabazitaxel + Estramustine DC3VZHC Cabazitaxel Plasma cell myeloma (Cell Line: RPMI-8226) [2]
Cabazitaxel + Estramustine DCQWLDO Cabazitaxel Prostate carcinoma (Cell Line: PC-3) [2]
Cabazitaxel + Estramustine DCXY7M1 Cabazitaxel Renal cell carcinoma (Cell Line: SN12C) [2]
Cabazitaxel + Estramustine DCX5ASX Cabazitaxel Breast adenocarcinoma (Cell Line: MDA-MB-468) [3]
Cabazitaxel + Estramustine DC1STTG Cabazitaxel Carcinoma (Cell Line: RXF 393) [3]
Cabazitaxel + Estramustine DCJJYTI Cabazitaxel Carcinoma (Cell Line: MCF7) [3]
Cabazitaxel + Estramustine DCSP3TQ Cabazitaxel Invasive ductal carcinoma (Cell Line: HS 578T) [3]
Cabazitaxel + Estramustine DC2BD07 Cabazitaxel Invasive ductal carcinoma (Cell Line: BT-549) [3]
Cabazitaxel + Estramustine DCB8VWC Cabazitaxel Invasive ductal carcinoma (Cell Line: T-47D) [3]
Cerivastatin + Estramustine DCBZ25J Cerivastatin Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Cisatracurium + Estramustine DCTMFRU Cisatracurium Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Citalopram + Estramustine DCX3UU2 Citalopram Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Crizotinib + Estramustine DCWVZFS Crizotinib Adenocarcinoma (Cell Line: DU-145) [2]
Crizotinib + Estramustine DCVRCDB Crizotinib Adenocarcinoma (Cell Line: OVCAR3) [2]
Crizotinib + Estramustine DCLLBME Crizotinib Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [2]
Crizotinib + Estramustine DC1T9Y9 Crizotinib Anaplastic large cell lymphoma (Cell Line: SR) [2]
Crizotinib + Estramustine DC72APL Crizotinib Clear cell renal cell carcinoma (Cell Line: 786-0) [2]
Crizotinib + Estramustine DCGHMIR Crizotinib Glioma (Cell Line: SF-268) [2]
Crizotinib + Estramustine DCRFUBG Crizotinib Large cell lung carcinoma (Cell Line: NCI-H460) [2]
Crizotinib + Estramustine DC6KJ1I Crizotinib Breast adenocarcinoma (Cell Line: MDA-MB-468) [3]
Crizotinib + Estramustine DC9ONZ0 Crizotinib Carcinoma (Cell Line: RXF 393) [3]
Crizotinib + Estramustine DC0LK47 Crizotinib Carcinoma (Cell Line: MCF7) [3]
Crizotinib + Estramustine DCITY2M Crizotinib Invasive ductal carcinoma (Cell Line: T-47D) [3]
Cycloguanil + Estramustine DCGI2NX Cycloguanil Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Dacarbazine + Estramustine DCEG185 Dacarbazine Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [2]
Dacarbazine + Estramustine DCRPCWB Dacarbazine Amelanotic melanoma (Cell Line: M14) [2]
Dacarbazine + Estramustine DCJOZSS Dacarbazine Chronic myelogenous leukemia (Cell Line: K-562) [2]
Dacarbazine + Estramustine DCLKTXP Dacarbazine Clear cell renal cell carcinoma (Cell Line: 786-0) [2]
Dactinomycin + Estramustine DCB2HJ7 Dactinomycin Adenocarcinoma (Cell Line: HCT116) [4]
Dactinomycin + Estramustine DC1TUN2 Dactinomycin Amelanotic melanoma (Cell Line: M14) [4]
Dexrazoxane + Estramustine DCSGCN7 Dexrazoxane Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [2]
Dexrazoxane + Estramustine DCENJWA Dexrazoxane Anaplastic large cell lymphoma (Cell Line: SR) [2]
Dexrazoxane + Estramustine DCTCFXE Dexrazoxane Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [2]
Dexrazoxane + Estramustine DCJCNB4 Dexrazoxane Colon adenocarcinoma (Cell Line: COLO 205) [3]
Dexrazoxane + Estramustine DCCJUTA Dexrazoxane Adenocarcinoma (Cell Line: HCT116) [4]
Dextromethorphan + Estramustine DCFZ7VK Dextromethorphan Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
DFN-15 + Estramustine DC8TWPZ DFN-15 Amelanotic melanoma (Cell Line: M14) [4]
DFN-15 + Estramustine DCRGAUF DFN-15 Lung adenocarcinoma (Cell Line: EKVX) [4]
Diazoxide + Estramustine DCK8BN4 Diazoxide Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Digitoxin + Estramustine DCGFAYN Digitoxin Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [2]
Digitoxin + Estramustine DCPHULZ Digitoxin Large cell lung carcinoma (Cell Line: NCI-H460) [2]
Digitoxin + Estramustine DC1ESK3 Digitoxin Malignant melanoma (Cell Line: UACC62) [2]
Digitoxin + Estramustine DCCHLJZ Digitoxin Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [2]
Digitoxin + Estramustine DCVSXTY Digitoxin Breast adenocarcinoma (Cell Line: MDA-MB-468) [3]
Emetine + Estramustine DCJBA3N Emetine Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Epinephrine + Estramustine DCSVX84 Epinephrine Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Epirubicin + Estramustine DCF4PJC Epirubicin Chronic myelogenous leukemia (Cell Line: K-562) [2]
Epirubicin + Estramustine DCXXNIG Epirubicin Clear cell renal cell carcinoma (Cell Line: TK-10) [2]
Epirubicin + Estramustine DCFV2CW Epirubicin Clear cell renal cell carcinoma (Cell Line: A498) [2]
Epirubicin + Estramustine DCUP9H4 Epirubicin Papillary renal cell carcinoma (Cell Line: ACHN) [2]
Epirubicin + Estramustine DCKXFLQ Epirubicin Renal cell carcinoma (Cell Line: UO-31) [2]
Epirubicin + Estramustine DC9FQ72 Epirubicin Carcinoma (Cell Line: MCF7) [3]
Epirubicin + Estramustine DCDR9DM Epirubicin Colon carcinoma (Cell Line: KM12) [3]
Epirubicin + Estramustine DCM0W2T Epirubicin Invasive ductal carcinoma (Cell Line: HS 578T) [3]
Epirubicin + Estramustine DC28FAJ Epirubicin Invasive ductal carcinoma (Cell Line: T-47D) [3]
Epirubicin + Estramustine DCF7JPA Epirubicin Invasive ductal carcinoma (Cell Line: BT-549) [3]
Epirubicin + Estramustine DC7F2C1 Epirubicin Adenocarcinoma (Cell Line: HCT116) [4]
Epirubicin + Estramustine DCROF7G Epirubicin Amelanotic melanoma (Cell Line: MDA-MB-435) [4]
Epirubicin + Estramustine DC2P8OZ Epirubicin High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [4]
Epirubicin + Estramustine DCBEFPM Epirubicin Malignant melanoma (Cell Line: LOX IMVI) [4]
Epirubicin + Estramustine DC2SO2M Epirubicin Melanoma (Cell Line: SK-MEL-2) [4]
Epirubicin + Estramustine DCOE03I Epirubicin Melanoma (Cell Line: UACC-257) [4]
Epirubicin + Estramustine DC78QVE Epirubicin Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [4]
Estramustine + Pentostatin DCD6IRM Pentostatin Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [2]
Estramustine + Pentostatin DCYBVPU Pentostatin Clear cell renal cell carcinoma (Cell Line: TK-10) [2]
Estramustine + Pentostatin DCZPBBD Pentostatin Glioblastoma (Cell Line: SNB-75) [2]
Estramustine + Pentostatin DCU3HIR Pentostatin Plasma cell myeloma (Cell Line: RPMI-8226) [2]
Estramustine + Mebutamate DCFEVOG Mebutamate Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Estramustine + Baclofen DC5KVCN Baclofen Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Estramustine + Fulvestrant DCFWXBJ Fulvestrant Renal cell carcinoma (Cell Line: SN12C) [2]
Estramustine + Acetazolamide DC3UA11 Acetazolamide Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Estramustine + PD-0325901 DCD5TK4 PD-0325901 Ewing sarcoma-peripheral primitive neuroectodermal tumour (Cell Line: ES2) [2]
Estramustine + Hepzato DCCIY7T Hepzato Clear cell renal cell carcinoma (Cell Line: TK-10) [2]
Estramustine + Ixabepilone DCPJA4U Ixabepilone Plasma cell myeloma (Cell Line: RPMI-8226) [2]
Estramustine + Dactinomycin DCX61F6 Dactinomycin Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [2]
Estramustine + Lapatinib DC5LW4X Lapatinib Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [2]
Estramustine + Lapatinib DCS78EW Lapatinib Astrocytoma (Cell Line: SNB-19) [2]
Estramustine + Lapatinib DCNYSFQ Lapatinib Clear cell renal cell carcinoma (Cell Line: CAKI-1) [2]
Estramustine + Lapatinib DCCHZAZ Lapatinib Ewing sarcoma-peripheral primitive neuroectodermal tumour (Cell Line: ES2) [2]
Estramustine + MK-1775 DCXBAE9 MK-1775 Ewing sarcoma-peripheral primitive neuroectodermal tumour (Cell Line: ES2) [2]
Estramustine + PMID28460551-Compound-2 DC8CRC4 PMID28460551-Compound-2 Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [2]
Estramustine + PMID28460551-Compound-2 DCKPGOR PMID28460551-Compound-2 Anaplastic large cell lymphoma (Cell Line: SR) [2]
Estramustine + PMID28460551-Compound-2 DCTG4KV PMID28460551-Compound-2 Ewing sarcoma-peripheral primitive neuroectodermal tumour (Cell Line: ES2) [2]
Estramustine + Cyclophosphamide DCABTWY Cyclophosphamide Anaplastic large cell lymphoma (Cell Line: SR) [2]
Estramustine + Isoniazid DCG3DU6 Isoniazid Glioma (Cell Line: SF-268) [2]
Estramustine + Vinblastine DCNSOS2 Vinblastine Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Estramustine + Arsenic trioxide DCLKGTA Arsenic trioxide Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [2]
Estramustine + RTB101 DCV8NO5 RTB101 Ewing sarcoma-peripheral primitive neuroectodermal tumour (Cell Line: ES2) [2]
Estramustine + SCH-900776 DCKJ8Q5 SCH-900776 Ewing sarcoma-peripheral primitive neuroectodermal tumour (Cell Line: ES2) [2]
Estramustine + Sivelestat DCV86NI Sivelestat Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Estramustine + Plicamycin DCIBW1D Plicamycin Clear cell renal cell carcinoma (Cell Line: CAKI-1) [2]
Estramustine + Testosterone DC99KXR Testosterone Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Estramustine + Nilotinib DCP0FVL Nilotinib Clear cell renal cell carcinoma (Cell Line: A498) [2]
Estramustine + Triapine DCTGKS6 Triapine Clear cell renal cell carcinoma (Cell Line: TK-10) [2]
Estramustine + Triapine DCBOLAN Triapine Clear cell renal cell carcinoma (Cell Line: 786-0) [2]
Estramustine + Triapine DCA1KTZ Triapine Clear cell renal cell carcinoma (Cell Line: CAKI-1) [2]
Estramustine + Acitretin DCMB0QF Acitretin Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Estramustine + Tranexamic acid DCCK2DZ Tranexamic acid Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Estramustine + 10-hydroxycamptothecin DC36IO0 10-hydroxycamptothecin Anaplastic large cell lymphoma (Cell Line: SR) [2]
Estramustine + Topetecan DCKAG1C Topetecan Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [2]
Estramustine + IT-141 DC0LPMP IT-141 Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Estramustine + SNX-2112 DCFQHPV SNX-2112 Ewing sarcoma-peripheral primitive neuroectodermal tumour (Cell Line: ES2) [2]
Estramustine + Terameprocol DCMLP1E Terameprocol Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Estramustine + Terameprocol DCLMFEE Terameprocol Plasma cell myeloma (Cell Line: RPMI-8226) [2]
Estramustine + SCH 727965 DCZXSUI SCH 727965 Ewing sarcoma-peripheral primitive neuroectodermal tumour (Cell Line: ES2) [2]
Estramustine + Erlotinib DCZCDJO Erlotinib Ewing sarcoma-peripheral primitive neuroectodermal tumour (Cell Line: ES2) [2]
Estramustine + Metformin DCC26Y9 Metformin Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Estramustine + Docetaxel DCU6B3V Docetaxel Anaplastic large cell lymphoma (Cell Line: SR) [2]
Estramustine + Raloxifene DCIGCKR Raloxifene Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [2]
Estramustine + Pazopanib DCTGWSY Pazopanib Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Estramustine + MK-5108 DCTUOIW MK-5108 Ewing sarcoma-peripheral primitive neuroectodermal tumour (Cell Line: ES2) [2]
Estramustine + Nizatidine DCQPZO7 Nizatidine Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Estramustine + Sirolimus DCIGSJ6 Sirolimus Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [2]
Estramustine + Sirolimus DC0O9HS Sirolimus Plasma cell myeloma (Cell Line: RPMI-8226) [2]
Estramustine + Mitomycin DCFX6C6 Mitomycin Chronic myelogenous leukemia (Cell Line: K-562) [2]
Estramustine + Mitomycin DCK0YS1 Mitomycin Glioma (Cell Line: SF-268) [2]
Estramustine + Bosentan DCRX9BN Bosentan Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Estramustine + Arfolitixorin DCTZKX6 Arfolitixorin Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Estramustine + Isoproterenol DCEUDFM Isoproterenol Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Estramustine + Altretamine DCR9B85 Altretamine Glioma (Cell Line: SF-295) [2]
Estramustine + Oseltamivir DC5CF9U Oseltamivir Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Estramustine + Ridaforolimus DCCVDSU Ridaforolimus Ewing sarcoma-peripheral primitive neuroectodermal tumour (Cell Line: ES2) [2]
Estramustine + MK-4827 DCCQWD8 MK-4827 Ewing sarcoma-peripheral primitive neuroectodermal tumour (Cell Line: ES2) [2]
Estramustine + Idarubicin DCFPOMS Idarubicin Glioblastoma? (Cell Line: T98G) [2]
Estramustine + Atenolol DC8K3YP Atenolol Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Estramustine + Pramipexole DCVWJ03 Pramipexole Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Estramustine + Bortezomib DCDPYGA Bortezomib Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [2]
Estramustine + Bortezomib DCWE0M0 Bortezomib Ewing sarcoma-peripheral primitive neuroectodermal tumour (Cell Line: ES2) [2]
Estramustine + Acamprosate DC9MG7S Acamprosate Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Estramustine + Valrubicin DCET2N6 Valrubicin Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [2]
Estramustine + Valrubicin DC7R4IV Valrubicin Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [2]
Estramustine + Valrubicin DCWA0K8 Valrubicin Anaplastic large cell lymphoma (Cell Line: SR) [2]
Estramustine + Valrubicin DCRRNX6 Valrubicin Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [2]
Estramustine + GSK525762 DCC43WJ GSK525762 Ewing sarcoma-peripheral primitive neuroectodermal tumour (Cell Line: ES2) [2]
Estramustine + Trimethobenzamide DCRG7DR Trimethobenzamide Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Estramustine + Maprotiline DC6OFX5 Maprotiline Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Estramustine + Cisplatin DCSYN3Z Cisplatin Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [2]
Estramustine + Cisplatin DCY15SS Cisplatin Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [2]
Estramustine + Chlorambucil DC44JQF Chlorambucil Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [2]
Estramustine + Chlorambucil DCMD0I5 Chlorambucil Anaplastic large cell lymphoma (Cell Line: SR) [2]
Estramustine + Chlorambucil DC5MRX7 Chlorambucil Clear cell renal cell carcinoma (Cell Line: 786-0) [2]
Estramustine + Chlorambucil DCPA30O Chlorambucil Glioma (Cell Line: SF-539) [2]
Estramustine + Amiloride DCVZSJD Amiloride Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Estramustine + Sorafenib DCNNO3T Sorafenib Ewing sarcoma-peripheral primitive neuroectodermal tumour (Cell Line: ES2) [2]
Estramustine + ER819762 DCM1UFT ER819762 Clear cell renal cell carcinoma (Cell Line: A498) [2]
Estramustine + ER819762 DCSFDLS ER819762 Glioma (Cell Line: SF-295) [2]
Estramustine + MK-2206 DCTDFON MK-2206 Ewing sarcoma-peripheral primitive neuroectodermal tumour (Cell Line: ES2) [2]
Estramustine + Romidepsin DCASYSX Romidepsin Glioma (Cell Line: SF-539) [2]
Estramustine + Romidepsin DCELB2J Romidepsin Papillary renal cell carcinoma (Cell Line: ACHN) [2]
Estramustine + Pomalidomide DCG00ZI Pomalidomide Clear cell renal cell carcinoma (Cell Line: TK-10) [2]
Estramustine + Vinflunine DCU8NLB Vinflunine Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [2]
Estramustine + Vinflunine DCKVGBL Vinflunine Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [2]
Estramustine + Vinflunine DCCJBWK Vinflunine Plasma cell myeloma (Cell Line: RPMI-8226) [2]
Estramustine + Endoxifen DCLQ3XR Endoxifen Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Estramustine + Mefloquine DCXPN3V Mefloquine Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Estramustine + Doxorubicin DC51LQ7 Doxorubicin Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Estramustine + Silver sulfadiazine DC3G3H8 Silver sulfadiazine Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Estramustine + Testolactone DCIPOBI Testolactone Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Estramustine + Olmesartan medoxomil DCUCFOW Olmesartan medoxomil Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Estramustine + PMID28870136-Compound-43 DC89TBB PMID28870136-Compound-43 Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [2]
Estramustine + PMID28870136-Compound-43 DCCJJ8H PMID28870136-Compound-43 Astrocytoma (Cell Line: SNB-19) [2]
Estramustine + PMID28870136-Compound-43 DCN4BVK PMID28870136-Compound-43 Plasma cell myeloma (Cell Line: RPMI-8226) [2]
Estramustine + FORMESTANE DCIDBD9 FORMESTANE Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [2]
Estramustine + FORMESTANE DCQETTW FORMESTANE Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [2]
Estramustine + FORMESTANE DCW6Q0R FORMESTANE Chronic myelogenous leukemia (Cell Line: K-562) [2]
Estramustine + FORMESTANE DCF9JZN FORMESTANE Clear cell renal cell carcinoma (Cell Line: 786-0) [2]
Estramustine + FORMESTANE DCH0NXT FORMESTANE Renal cell carcinoma (Cell Line: SN12C) [2]
Estramustine + Vorinostat DC5GRBC Vorinostat Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Estramustine + Aminolevulinic Acid Hydrochloride DCZL1ZQ Aminolevulinic Acid Hydrochloride Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [2]
Estramustine + Aminolevulinic Acid Hydrochloride DCA8GKF Aminolevulinic Acid Hydrochloride Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [2]
Estramustine + Aminolevulinic Acid Hydrochloride DCY0QWA Aminolevulinic Acid Hydrochloride Anaplastic large cell lymphoma (Cell Line: SR) [2]
Estramustine + Aminolevulinic Acid Hydrochloride DCNVSHS Aminolevulinic Acid Hydrochloride Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [2]
Estramustine + Aminolevulinic Acid Hydrochloride DCFRIED Aminolevulinic Acid Hydrochloride Renal cell carcinoma (Cell Line: SN12C) [2]
Estramustine + Cevimeline DCYQ06D Cevimeline Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Estramustine + Acetohydroxamic Acid DCOHLZX Acetohydroxamic Acid Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Estramustine + Dasatinib DC3LBJD Dasatinib Adenocarcinoma (Cell Line: COLO320DM) [2]
Estramustine + Dasatinib DCX2TI9 Dasatinib Adenocarcinoma (Cell Line: SW-620) [2]
Estramustine + Dasatinib DC3NAQ0 Dasatinib Astrocytoma (Cell Line: U251) [2]
Estramustine + Dasatinib DCL04VR Dasatinib Ewing sarcoma-peripheral primitive neuroectodermal tumour (Cell Line: ES2) [2]
Estramustine + Pentostatin DCWQG7C Pentostatin Carcinoma (Cell Line: RXF 393) [3]
Estramustine + Pentostatin DCPXYQ4 Pentostatin Carcinoma (Cell Line: MCF7) [3]
Estramustine + Pentostatin DCIKBP8 Pentostatin Colon carcinoma (Cell Line: KM12) [3]
Estramustine + Pentostatin DCG92UG Pentostatin Invasive ductal carcinoma (Cell Line: HS 578T) [3]
Estramustine + PD-0325901 DC4ME60 PD-0325901 Breast and ovarian cancer syndrome (Cell Line: UWB1289) [3]
Estramustine + PD-0325901 DC1M5U6 PD-0325901 Breast and ovarian cancer syndrome (Cell Line: UWB1289+BRCA1) [3]
Estramustine + PD-0325901 DC9Y4P6 PD-0325901 Breast carcinoma (Cell Line: KPL1) [3]
Estramustine + PD-0325901 DCP63WV PD-0325901 Breast carcinoma (Cell Line: OCUBM) [3]
Estramustine + PD-0325901 DCOY2BX PD-0325901 Carcinoma (Cell Line: EFM192B) [3]
Estramustine + PD-0325901 DCG4CYY PD-0325901 Carcinoma (Cell Line: MDAMB436) [3]
Estramustine + PD-0325901 DC3V8OT PD-0325901 Invasive ductal carcinoma (Cell Line: T-47D) [3]
Estramustine + Hepzato DCBLO78 Hepzato Colon adenocarcinoma (Cell Line: COLO 205) [3]
Estramustine + Lapatinib DC53W8K Lapatinib Breast and ovarian cancer syndrome (Cell Line: UWB1289) [3]
Estramustine + Lapatinib DCSKY5K Lapatinib Breast and ovarian cancer syndrome (Cell Line: UWB1289+BRCA1) [3]
Estramustine + Lapatinib DC6X31P Lapatinib Breast carcinoma (Cell Line: OCUBM) [3]
Estramustine + Lapatinib DCPCMFB Lapatinib Colon adenocarcinoma (Cell Line: LOVO) [3]
Estramustine + MK-1775 DC8RIYX MK-1775 Breast and ovarian cancer syndrome (Cell Line: UWB1289) [3]
Estramustine + MK-1775 DC05PAU MK-1775 Breast carcinoma (Cell Line: OCUBM) [3]
Estramustine + MK-1775 DCL04CS MK-1775 Carcinoma (Cell Line: EFM192B) [3]
Estramustine + MK-1775 DCFP73J MK-1775 Colon adenocarcinoma (Cell Line: LOVO) [3]
Estramustine + MK-1775 DCCGIN3 MK-1775 Invasive ductal carcinoma (Cell Line: T-47D) [3]
Estramustine + PMID28460551-Compound-2 DC7M3ZD PMID28460551-Compound-2 Breast adenocarcinoma (Cell Line: MDA-MB-468) [3]
Estramustine + PMID28460551-Compound-2 DC09MZ4 PMID28460551-Compound-2 Breast and ovarian cancer syndrome (Cell Line: UWB1289) [3]
Estramustine + PMID28460551-Compound-2 DCUCCCO PMID28460551-Compound-2 Breast and ovarian cancer syndrome (Cell Line: UWB1289+BRCA1) [3]
Estramustine + PMID28460551-Compound-2 DCIOK9T PMID28460551-Compound-2 Breast carcinoma (Cell Line: ZR751) [3]
Estramustine + PMID28460551-Compound-2 DCS9Q84 PMID28460551-Compound-2 Breast carcinoma (Cell Line: OCUBM) [3]
Estramustine + PMID28460551-Compound-2 DC67S5H PMID28460551-Compound-2 Carcinoma (Cell Line: EFM192B) [3]
Estramustine + PMID28460551-Compound-2 DCPATI4 PMID28460551-Compound-2 Carcinoma (Cell Line: MDAMB436) [3]
Estramustine + Isoniazid DCKXMZI Isoniazid Breast adenocarcinoma (Cell Line: MDA-MB-468) [3]
Estramustine + Isoniazid DCSNZOI Isoniazid Invasive ductal carcinoma (Cell Line: BT-549) [3]
Estramustine + Arsenic trioxide DCR5YEM Arsenic trioxide Invasive ductal carcinoma (Cell Line: BT-549) [3]
Estramustine + RTB101 DC4XUI4 RTB101 Breast and ovarian cancer syndrome (Cell Line: UWB1289) [3]
Estramustine + RTB101 DC3GT33 RTB101 Breast and ovarian cancer syndrome (Cell Line: UWB1289+BRCA1) [3]
Estramustine + RTB101 DCNYEZ5 RTB101 Breast carcinoma (Cell Line: OCUBM) [3]
Estramustine + RTB101 DC29LSD RTB101 Carcinoma (Cell Line: OV90) [3]
Estramustine + RTB101 DCFL1OS RTB101 Carcinoma (Cell Line: EFM192B) [3]
Estramustine + RTB101 DCNC4GN RTB101 Colon adenocarcinoma (Cell Line: LOVO) [3]
Estramustine + RTB101 DC3CRWQ RTB101 Invasive ductal carcinoma (Cell Line: T-47D) [3]
Estramustine + SCH-900776 DCZQZ8O SCH-900776 Breast and ovarian cancer syndrome (Cell Line: UWB1289) [3]
Estramustine + SCH-900776 DC6PA6A SCH-900776 Breast and ovarian cancer syndrome (Cell Line: UWB1289+BRCA1) [3]
Estramustine + SCH-900776 DCMVT6M SCH-900776 Breast carcinoma (Cell Line: KPL1) [3]
Estramustine + SCH-900776 DCTOA3M SCH-900776 Breast carcinoma (Cell Line: OCUBM) [3]
Estramustine + SCH-900776 DCD8FR0 SCH-900776 Carcinoma (Cell Line: OV90) [3]
Estramustine + SCH-900776 DCVAV01 SCH-900776 Carcinoma (Cell Line: EFM192B) [3]
Estramustine + SCH-900776 DCH7NKT SCH-900776 Carcinoma (Cell Line: MDAMB436) [3]
Estramustine + SCH-900776 DCGL4IA SCH-900776 Colon adenocarcinoma (Cell Line: LOVO) [3]
Estramustine + SCH-900776 DCYEI30 SCH-900776 Invasive ductal carcinoma (Cell Line: T-47D) [3]
Estramustine + Plicamycin DCPQZK6 Plicamycin Carcinoma (Cell Line: MCF7) [3]
Estramustine + Plicamycin DCGLHDL Plicamycin Invasive ductal carcinoma (Cell Line: T-47D) [3]
Estramustine + 10-hydroxycamptothecin DCZVNDY 10-hydroxycamptothecin Breast adenocarcinoma (Cell Line: MDA-MB-468) [3]
Estramustine + Topetecan DCDYNQG Topetecan Breast adenocarcinoma (Cell Line: MDA-MB-468) [3]
Estramustine + SNX-2112 DC2FA0Q SNX-2112 Breast and ovarian cancer syndrome (Cell Line: UWB1289) [3]
Estramustine + SNX-2112 DCHGXC1 SNX-2112 Breast carcinoma (Cell Line: OCUBM) [3]
Estramustine + SNX-2112 DC8ODZZ SNX-2112 Carcinoma (Cell Line: EFM192B) [3]
Estramustine + SNX-2112 DCUBY2F SNX-2112 Colon adenocarcinoma (Cell Line: LOVO) [3]
Estramustine + SNX-2112 DCASG5S SNX-2112 Invasive ductal carcinoma (Cell Line: T-47D) [3]
Estramustine + Terameprocol DC2EM13 Terameprocol Carcinoma (Cell Line: MCF7) [3]
Estramustine + Terameprocol DCGHEC2 Terameprocol Colon carcinoma (Cell Line: KM12) [3]
Estramustine + SCH 727965 DCYZL15 SCH 727965 Breast and ovarian cancer syndrome (Cell Line: UWB1289) [3]
Estramustine + SCH 727965 DCSZM88 SCH 727965 Breast and ovarian cancer syndrome (Cell Line: UWB1289+BRCA1) [3]
Estramustine + SCH 727965 DCQZ08X SCH 727965 Breast carcinoma (Cell Line: OCUBM) [3]
Estramustine + SCH 727965 DCX96NX SCH 727965 Colon adenocarcinoma (Cell Line: LOVO) [3]
Estramustine + SCH 727965 DCMEIR7 SCH 727965 Colon adenocarcinoma (Cell Line: COLO 205) [3]
Estramustine + SCH 727965 DCYQXMH SCH 727965 Invasive ductal carcinoma (Cell Line: T-47D) [3]
Estramustine + Erlotinib DCL87OK Erlotinib Breast and ovarian cancer syndrome (Cell Line: UWB1289+BRCA1) [3]
Estramustine + Erlotinib DCSDGM8 Erlotinib Breast carcinoma (Cell Line: OCUBM) [3]
Estramustine + Erlotinib DC84A3A Erlotinib Carcinoma (Cell Line: EFM192B) [3]
Estramustine + Erlotinib DCUCEBZ Erlotinib Colon adenocarcinoma (Cell Line: LOVO) [3]
Estramustine + Erlotinib DC1XT6A Erlotinib Colon carcinoma (Cell Line: RKO) [3]
Estramustine + Erlotinib DC07Z8U Erlotinib Invasive ductal carcinoma (Cell Line: T-47D) [3]
Estramustine + MK-5108 DCK59SF MK-5108 Breast carcinoma (Cell Line: OCUBM) [3]
Estramustine + MK-5108 DC94B58 MK-5108 Carcinoma (Cell Line: EFM192B) [3]
Estramustine + MK-5108 DC77C9F MK-5108 Colon carcinoma (Cell Line: RKO) [3]
Estramustine + Mitomycin DC97WX0 Mitomycin Breast adenocarcinoma (Cell Line: MDA-MB-468) [3]
Estramustine + Mitomycin DCL1XI7 Mitomycin Invasive ductal carcinoma (Cell Line: BT-549) [3]
Estramustine + Altretamine DC67BLF Altretamine Breast adenocarcinoma (Cell Line: MDA-MB-468) [3]
Estramustine + Ridaforolimus DCCAMEO Ridaforolimus Breast carcinoma (Cell Line: KPL1) [3]
Estramustine + MK-4827 DCVDU6R MK-4827 Breast and ovarian cancer syndrome (Cell Line: UWB1289) [3]
Estramustine + MK-4827 DC6QP93 MK-4827 Breast and ovarian cancer syndrome (Cell Line: UWB1289+BRCA1) [3]
Estramustine + MK-4827 DCSBN29 MK-4827 Breast carcinoma (Cell Line: OCUBM) [3]
Estramustine + MK-4827 DC5PXLZ MK-4827 Carcinoma (Cell Line: EFM192B) [3]
Estramustine + MK-4827 DCHGZDS MK-4827 Carcinoma (Cell Line: MDAMB436) [3]
Estramustine + MK-4827 DCMQAS5 MK-4827 Colon adenocarcinoma (Cell Line: LOVO) [3]
Estramustine + MK-4827 DCBTL6K MK-4827 Colon carcinoma (Cell Line: RKO) [3]
Estramustine + MK-4827 DC44DUE MK-4827 Rectal adenocarcinoma (Cell Line: SW837) [3]
Estramustine + Idarubicin DCGW8SB Idarubicin Breast carcinoma (Cell Line: KPL1) [3]
Estramustine + Idarubicin DCJJK8P Idarubicin Colon carcinoma (Cell Line: RKO) [3]
Estramustine + Imatinib DCTUEGY Imatinib Carcinoma (Cell Line: MCF7) [3]
Estramustine + Bortezomib DC6Z28G Bortezomib Breast adenocarcinoma (Cell Line: MDA-MB-468) [3]
Estramustine + Bortezomib DCIQNI2 Bortezomib Breast carcinoma (Cell Line: KPL1) [3]
Estramustine + Bortezomib DCS5JFC Bortezomib Carcinoma (Cell Line: OV90) [3]
Estramustine + Bortezomib DCI30V1 Bortezomib Carcinoma (Cell Line: EFM192B) [3]
Estramustine + Bortezomib DCQWP0C Bortezomib Colon adenocarcinoma (Cell Line: LOVO) [3]
Estramustine + Bortezomib DCN180D Bortezomib Colon carcinoma (Cell Line: KM12) [3]
Estramustine + Bortezomib DCLU3ND Bortezomib Invasive ductal carcinoma (Cell Line: T-47D) [3]
Estramustine + Bortezomib DCZMVI2 Bortezomib Rectal adenocarcinoma (Cell Line: SW837) [3]
Estramustine + GSK525762 DCLRTPP GSK525762 Breast carcinoma (Cell Line: KPL1) [3]
Estramustine + GSK525762 DCPVF55 GSK525762 Breast carcinoma (Cell Line: OCUBM) [3]
Estramustine + GSK525762 DC2NL91 GSK525762 Carcinoma (Cell Line: EFM192B) [3]
Estramustine + GSK525762 DCEADE5 GSK525762 Carcinoma (Cell Line: MDAMB436) [3]
Estramustine + GSK525762 DCK6ESG GSK525762 Colon carcinoma (Cell Line: RKO) [3]
Estramustine + GSK525762 DCCDUD3 GSK525762 Rectal adenocarcinoma (Cell Line: SW837) [3]
Estramustine + Cisplatin DCTPY3Q Cisplatin Carcinoma (Cell Line: RXF 393) [3]
Estramustine + Chlorambucil DCLWALV Chlorambucil Breast adenocarcinoma (Cell Line: MDA-MB-468) [3]
Estramustine + Sorafenib DCWW1Y3 Sorafenib Breast carcinoma (Cell Line: ZR751) [3]
Estramustine + Sorafenib DCDGI9B Sorafenib Invasive ductal carcinoma (Cell Line: T-47D) [3]
Estramustine + ER819762 DCSUTXN ER819762 Carcinoma (Cell Line: RXF 393) [3]
Estramustine + ER819762 DCGIKGG ER819762 Carcinoma (Cell Line: MCF7) [3]
Estramustine + MK-2206 DCCD4HU MK-2206 Breast and ovarian cancer syndrome (Cell Line: UWB1289) [3]
Estramustine + MK-2206 DCG8OD9 MK-2206 Breast and ovarian cancer syndrome (Cell Line: UWB1289+BRCA1) [3]
Estramustine + MK-2206 DC1ILR3 MK-2206 Carcinoma (Cell Line: MDAMB436) [3]
Estramustine + MK-2206 DC42RQI MK-2206 Colon carcinoma (Cell Line: RKO) [3]
Estramustine + Romidepsin DCIVBZX Romidepsin Invasive ductal carcinoma (Cell Line: HS 578T) [3]
Estramustine + Pomalidomide DCSQM1O Pomalidomide Invasive ductal carcinoma (Cell Line: HS 578T) [3]
Estramustine + Mepacrine DCCMPTG Mepacrine Colon carcinoma (Cell Line: KM12) [3]
Estramustine + FORMESTANE DCRTG1K FORMESTANE Carcinoma (Cell Line: MCF7) [3]
Estramustine + Dasatinib DCIA5Y2 Dasatinib Breast carcinoma (Cell Line: KPL1) [3]
Estramustine + Dasatinib DCGOVD5 Dasatinib Breast carcinoma (Cell Line: OCUBM) [3]
Estramustine + Dasatinib DCL4P5M Dasatinib Carcinoma (Cell Line: EFM192B) [3]
Estramustine + Dasatinib DCPNS07 Dasatinib Carcinoma (Cell Line: MDAMB436) [3]
Estramustine + Dasatinib DCF83WE Dasatinib Colon adenocarcinoma (Cell Line: LOVO) [3]
Estramustine + Dasatinib DCIXN5E Dasatinib Invasive ductal carcinoma (Cell Line: T-47D) [3]
Estramustine + Pentostatin DCJWJ1Y Pentostatin Adenocarcinoma (Cell Line: NCIH23) [4]
Estramustine + Pentostatin DCWPTJB Pentostatin High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4) [4]
Estramustine + Pentostatin DCTRY48 Pentostatin Melanoma (Cell Line: SK-MEL-2) [4]
Estramustine + Fulvestrant DCUBQ1P Fulvestrant Adenocarcinoma (Cell Line: HCC-2998) [4]
Estramustine + Fulvestrant DC4NTFJ Fulvestrant Lung adenocarcinoma (Cell Line: EKVX) [4]
Estramustine + PD-0325901 DC0545T PD-0325901 Adenocarcinoma (Cell Line: CAOV3) [4]
Estramustine + PD-0325901 DCQ9F0P PD-0325901 Adenocarcinoma (Cell Line: OVCAR3) [4]
Estramustine + PD-0325901 DCYDEED PD-0325901 Adenocarcinoma (Cell Line: A427) [4]
Estramustine + PD-0325901 DCSQQVH PD-0325901 Adenocarcinoma (Cell Line: NCIH2122) [4]
Estramustine + PD-0325901 DC44G0T PD-0325901 Adenocarcinoma (Cell Line: NCIH23) [4]
Estramustine + PD-0325901 DCFRU69 PD-0325901 Adenocarcinoma (Cell Line: NCIH520) [4]
Estramustine + PD-0325901 DC58FB5 PD-0325901 Adenocarcinoma (Cell Line: COLO320DM) [4]
Estramustine + PD-0325901 DCPPMJ9 PD-0325901 Adenocarcinoma (Cell Line: DLD1) [4]
Estramustine + PD-0325901 DC81XCM PD-0325901 Adenocarcinoma (Cell Line: HT29) [4]
Estramustine + PD-0325901 DCTSPB4 PD-0325901 Amelanotic melanoma (Cell Line: A2058) [4]
Estramustine + PD-0325901 DCKZ09N PD-0325901 Germ cell tumour (Cell Line: PA1) [4]
Estramustine + PD-0325901 DCIT9L4 PD-0325901 Large cell lung carcinoma (Cell Line: NCI-H460) [4]
Estramustine + PD-0325901 DCZ9WJC PD-0325901 Malignant melanoma (Cell Line: A375) [4]
Estramustine + PD-0325901 DCV1I7W PD-0325901 Malignant melanoma (Cell Line: HT144) [4]
Estramustine + PD-0325901 DC95CGP PD-0325901 Malignant melanoma (Cell Line: RPMI7951) [4]
Estramustine + PD-0325901 DC14T11 PD-0325901 Malignant melanoma (Cell Line: SKMEL30) [4]
Estramustine + PD-0325901 DC13469 PD-0325901 Malignant melanoma (Cell Line: UACC62) [4]
Estramustine + PD-0325901 DCHHF1E PD-0325901 Mesothelioma (Cell Line: MSTO) [4]
Estramustine + PD-0325901 DC51QDF PD-0325901 Non small cell carcinoma (Cell Line: SKMES1) [4]
Estramustine + PD-0325901 DCCIIBJ PD-0325901 Ovarian endometrioid adenocarcinoma (Cell Line: A2780) [4]
Estramustine + PD-0325901 DC2OOVD PD-0325901 Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [4]
Estramustine + PD-0325901 DC68JS8 PD-0325901 Prostate carcinoma (Cell Line: VCAP) [4]
Estramustine + Hepzato DC788KY Hepzato Adenocarcinoma (Cell Line: HT29) [4]
Estramustine + Ixabepilone DCITS02 Ixabepilone Large cell lung carcinoma (Cell Line: NCI-H460) [4]
Estramustine + Dactinomycin DCFVNV7 Dactinomycin Melanoma (Cell Line: SK-MEL-2) [4]
Estramustine + Lapatinib DCVT40H Lapatinib Adenocarcinoma (Cell Line: A427) [4]
Estramustine + Lapatinib DCDKD5R Lapatinib Adenocarcinoma (Cell Line: NCIH23) [4]
Estramustine + Lapatinib DCWN5Z7 Lapatinib Adenocarcinoma (Cell Line: COLO320DM) [4]
Estramustine + Lapatinib DCPR9UN Lapatinib Amelanotic melanoma (Cell Line: A2058) [4]
Estramustine + Lapatinib DCF3OJV Lapatinib Malignant melanoma (Cell Line: A375) [4]
Estramustine + Lapatinib DCNX1PB Lapatinib Malignant melanoma (Cell Line: RPMI7951) [4]
Estramustine + Lapatinib DC38H8P Lapatinib Malignant melanoma (Cell Line: UACC62) [4]
Estramustine + Lapatinib DCZSLMU Lapatinib Ovarian endometrioid adenocarcinoma (Cell Line: A2780) [4]
Estramustine + Lapatinib DCO6WCA Lapatinib Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [4]
Estramustine + MK-1775 DC32TT3 MK-1775 Adenocarcinoma (Cell Line: CAOV3) [4]
Estramustine + MK-1775 DCYRSFL MK-1775 Adenocarcinoma (Cell Line: A427) [4]
Estramustine + MK-1775 DCMW6FP MK-1775 Adenocarcinoma (Cell Line: NCIH2122) [4]
Estramustine + MK-1775 DC5Q9HY MK-1775 Adenocarcinoma (Cell Line: NCIH520) [4]
Estramustine + MK-1775 DCSF1LK MK-1775 Adenocarcinoma (Cell Line: COLO320DM) [4]
Estramustine + MK-1775 DC61LSG MK-1775 Adenocarcinoma (Cell Line: DLD1) [4]
Estramustine + MK-1775 DCA5QO6 MK-1775 Adenocarcinoma (Cell Line: HT29) [4]
Estramustine + MK-1775 DCIZKVL MK-1775 Adenocarcinoma (Cell Line: SW-620) [4]
Estramustine + MK-1775 DCASYQW MK-1775 Amelanotic melanoma (Cell Line: A2058) [4]
Estramustine + MK-1775 DCS0RVF MK-1775 Germ cell tumour (Cell Line: PA1) [4]
Estramustine + MK-1775 DCLJNJ2 MK-1775 Malignant melanoma (Cell Line: A375) [4]
Estramustine + MK-1775 DCO8IQQ MK-1775 Malignant melanoma (Cell Line: HT144) [4]
Estramustine + MK-1775 DCS0WS5 MK-1775 Malignant melanoma (Cell Line: RPMI7951) [4]
Estramustine + MK-1775 DCE6FX0 MK-1775 Malignant melanoma (Cell Line: SKMEL30) [4]
Estramustine + MK-1775 DC9SD03 MK-1775 Mesothelioma (Cell Line: MSTO) [4]
Estramustine + MK-1775 DC8484L MK-1775 Non small cell carcinoma (Cell Line: SKMES1) [4]
Estramustine + MK-1775 DCJBZYW MK-1775 Ovarian endometrioid adenocarcinoma (Cell Line: A2780) [4]
Estramustine + PMID28460551-Compound-2 DC52W2O PMID28460551-Compound-2 Adenocarcinoma (Cell Line: CAOV3) [4]
Estramustine + PMID28460551-Compound-2 DCJXN5N PMID28460551-Compound-2 Adenocarcinoma (Cell Line: NCIH520) [4]
Estramustine + PMID28460551-Compound-2 DC7YMCU PMID28460551-Compound-2 Adenocarcinoma (Cell Line: SW-620) [4]
Estramustine + PMID28460551-Compound-2 DCI2OZQ PMID28460551-Compound-2 Amelanotic melanoma (Cell Line: A2058) [4]
Estramustine + PMID28460551-Compound-2 DCXSS62 PMID28460551-Compound-2 Large cell lung carcinoma (Cell Line: NCI-H460) [4]
Estramustine + PMID28460551-Compound-2 DCG8YZN PMID28460551-Compound-2 Malignant melanoma (Cell Line: A375) [4]
Estramustine + PMID28460551-Compound-2 DCT0BHE PMID28460551-Compound-2 Malignant melanoma (Cell Line: RPMI7951) [4]
Estramustine + PMID28460551-Compound-2 DCBH5XZ PMID28460551-Compound-2 Malignant melanoma (Cell Line: SKMEL30) [4]
Estramustine + PMID28460551-Compound-2 DCBFHH5 PMID28460551-Compound-2 Malignant melanoma (Cell Line: UACC62) [4]
Estramustine + PMID28460551-Compound-2 DCYQ2EV PMID28460551-Compound-2 Mesothelioma (Cell Line: MSTO) [4]
Estramustine + PMID28460551-Compound-2 DCUX3UT PMID28460551-Compound-2 Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [4]
Estramustine + PMID28460551-Compound-2 DC6WGLU PMID28460551-Compound-2 Non small cell carcinoma (Cell Line: SKMES1) [4]
Estramustine + PMID28460551-Compound-2 DCVCNJG PMID28460551-Compound-2 Ovarian endometrioid adenocarcinoma (Cell Line: A2780) [4]
Estramustine + PMID28460551-Compound-2 DCTVVO6 PMID28460551-Compound-2 Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [4]
Estramustine + PMID28460551-Compound-2 DCDQNUM PMID28460551-Compound-2 Prostate carcinoma (Cell Line: LNCAP) [4]
Estramustine + Cyclophosphamide DCBB37K Cyclophosphamide Adenocarcinoma (Cell Line: OVCAR3) [4]
Estramustine + Cyclophosphamide DCX5BFU Cyclophosphamide Adenocarcinoma (Cell Line: HCT116) [4]
Estramustine + Isoniazid DC11R6Z Isoniazid Adenocarcinoma (Cell Line: DU-145) [4]
Estramustine + Isoniazid DCHKN3J Isoniazid Adenocarcinoma (Cell Line: OVCAR3) [4]
Estramustine + Isoniazid DCZISWV Isoniazid Cutaneous melanoma (Cell Line: SK-MEL-28) [4]
Estramustine + Isoniazid DCC99EB Isoniazid High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [4]
Estramustine + Isoniazid DCO6WU8 Isoniazid Lung adenocarcinoma (Cell Line: HOP-62) [4]
Estramustine + Isoniazid DC0F79J Isoniazid Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [4]
Estramustine + Arsenic trioxide DCROPAZ Arsenic trioxide Malignant melanoma (Cell Line: LOX IMVI) [4]
Estramustine + Arsenic trioxide DC64NA8 Arsenic trioxide Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [4]
Estramustine + RTB101 DCMD25L RTB101 Adenocarcinoma (Cell Line: CAOV3) [4]
Estramustine + RTB101 DC570BS RTB101 Adenocarcinoma (Cell Line: A427) [4]
Estramustine + RTB101 DCZS4BT RTB101 Adenocarcinoma (Cell Line: NCIH2122) [4]
Estramustine + RTB101 DCBUFC7 RTB101 Adenocarcinoma (Cell Line: NCIH23) [4]
Estramustine + RTB101 DCVWAVK RTB101 Adenocarcinoma (Cell Line: NCIH520) [4]
Estramustine + RTB101 DCVH6SS RTB101 Adenocarcinoma (Cell Line: DLD1) [4]
Estramustine + RTB101 DC0T7S2 RTB101 Adenocarcinoma (Cell Line: HT29) [4]
Estramustine + RTB101 DC9S79Y RTB101 Adenocarcinoma (Cell Line: SW-620) [4]
Estramustine + RTB101 DCQ7QFU RTB101 Amelanotic melanoma (Cell Line: A2058) [4]
Estramustine + RTB101 DCZYUWT RTB101 Germ cell tumour (Cell Line: PA1) [4]
Estramustine + RTB101 DCSWDPY RTB101 Large cell lung carcinoma (Cell Line: NCI-H460) [4]
Estramustine + RTB101 DCSDG9F RTB101 Malignant melanoma (Cell Line: A375) [4]
Estramustine + RTB101 DCSC9W4 RTB101 Malignant melanoma (Cell Line: HT144) [4]
Estramustine + RTB101 DCAIK3M RTB101 Malignant melanoma (Cell Line: RPMI7951) [4]
Estramustine + RTB101 DCK7ZE1 RTB101 Malignant melanoma (Cell Line: SKMEL30) [4]
Estramustine + RTB101 DC1SDJJ RTB101 Mesothelioma (Cell Line: MSTO) [4]
Estramustine + RTB101 DC862TP RTB101 Non small cell carcinoma (Cell Line: SKMES1) [4]
Estramustine + RTB101 DC8ZEIC RTB101 Ovarian endometrioid adenocarcinoma (Cell Line: A2780) [4]
Estramustine + RTB101 DC8BFJC RTB101 Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [4]
Estramustine + SCH-900776 DCVOP7Q SCH-900776 Adenocarcinoma (Cell Line: CAOV3) [4]
Estramustine + SCH-900776 DC12K7A SCH-900776 Adenocarcinoma (Cell Line: OVCAR3) [4]
Estramustine + SCH-900776 DCGWSD1 SCH-900776 Adenocarcinoma (Cell Line: NCIH23) [4]
Estramustine + SCH-900776 DCODMCR SCH-900776 Adenocarcinoma (Cell Line: NCIH520) [4]
Estramustine + SCH-900776 DCASNHG SCH-900776 Adenocarcinoma (Cell Line: COLO320DM) [4]
Estramustine + SCH-900776 DC8NXMH SCH-900776 Adenocarcinoma (Cell Line: HT29) [4]
Estramustine + SCH-900776 DC8KCAR SCH-900776 Amelanotic melanoma (Cell Line: A2058) [4]
Estramustine + SCH-900776 DCHN4GA SCH-900776 Germ cell tumour (Cell Line: PA1) [4]
Estramustine + SCH-900776 DCBXIRD SCH-900776 Large cell lung carcinoma (Cell Line: NCI-H460) [4]
Estramustine + SCH-900776 DC9MSVH SCH-900776 Malignant melanoma (Cell Line: A375) [4]
Estramustine + SCH-900776 DCVGC4Q SCH-900776 Malignant melanoma (Cell Line: HT144) [4]
Estramustine + SCH-900776 DCV6X24 SCH-900776 Malignant melanoma (Cell Line: RPMI7951) [4]
Estramustine + SCH-900776 DCBSU7P SCH-900776 Malignant melanoma (Cell Line: SKMEL30) [4]
Estramustine + SCH-900776 DCHM2QK SCH-900776 Malignant melanoma (Cell Line: UACC62) [4]
Estramustine + SCH-900776 DC5PIBS SCH-900776 Mesothelioma (Cell Line: MSTO) [4]
Estramustine + SCH-900776 DC47NSK SCH-900776 Non small cell carcinoma (Cell Line: SKMES1) [4]
Estramustine + SCH-900776 DCQOYSF SCH-900776 Ovarian endometrioid adenocarcinoma (Cell Line: A2780) [4]
Estramustine + SCH-900776 DC1XDU9 SCH-900776 Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [4]
Estramustine + Plicamycin DCP6UYX Plicamycin Adenocarcinoma (Cell Line: OVCAR3) [4]
Estramustine + Plicamycin DC3RORH Plicamycin Lung adenocarcinoma (Cell Line: EKVX) [4]
Estramustine + Nilotinib DCDOFJM Nilotinib Adenocarcinoma (Cell Line: HCT116) [4]
Estramustine + Nilotinib DCDDA2O Nilotinib Adenocarcinoma (Cell Line: HT29) [4]
Estramustine + Nilotinib DCK3APO Nilotinib Amelanotic melanoma (Cell Line: MDA-MB-435) [4]
Estramustine + Nilotinib DCPS3LA Nilotinib Lung adenocarcinoma (Cell Line: HOP-62) [4]
Estramustine + Nilotinib DCXLCEY Nilotinib Malignant melanoma (Cell Line: LOX IMVI) [4]
Estramustine + Triapine DCDZ98U Triapine Adenocarcinoma (Cell Line: HCT116) [4]
Estramustine + 10-hydroxycamptothecin DCBH8D7 10-hydroxycamptothecin Adenocarcinoma (Cell Line: SW-620) [4]
Estramustine + Topetecan DCVJ74G Topetecan Melanoma (Cell Line: SK-MEL-2) [4]
Estramustine + Topetecan DC475B7 Topetecan Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [4]
Estramustine + Pralatrexate DCHIETW Pralatrexate Adenocarcinoma (Cell Line: HCT116) [4]
Estramustine + SNX-2112 DCY7NYM SNX-2112 Adenocarcinoma (Cell Line: CAOV3) [4]
Estramustine + SNX-2112 DCWAD34 SNX-2112 Adenocarcinoma (Cell Line: OVCAR3) [4]
Estramustine + SNX-2112 DCD6V9Z SNX-2112 Adenocarcinoma (Cell Line: NCIH2122) [4]
Estramustine + SNX-2112 DCT8LM1 SNX-2112 Adenocarcinoma (Cell Line: COLO320DM) [4]
Estramustine + SNX-2112 DCSG1M5 SNX-2112 Adenocarcinoma (Cell Line: DLD1) [4]
Estramustine + SNX-2112 DCP3NN8 SNX-2112 Amelanotic melanoma (Cell Line: A2058) [4]
Estramustine + SNX-2112 DCYVWGR SNX-2112 Malignant melanoma (Cell Line: A375) [4]
Estramustine + SNX-2112 DCWXPPS SNX-2112 Malignant melanoma (Cell Line: RPMI7951) [4]
Estramustine + SNX-2112 DC78TZX SNX-2112 Malignant melanoma (Cell Line: SKMEL30) [4]
Estramustine + SNX-2112 DC04W3O SNX-2112 Mesothelioma (Cell Line: MSTO) [4]
Estramustine + SNX-2112 DCUSUS6 SNX-2112 Non small cell carcinoma (Cell Line: SKMES1) [4]
Estramustine + SNX-2112 DCLH11P SNX-2112 Ovarian endometrioid adenocarcinoma (Cell Line: A2780) [4]
Estramustine + SNX-2112 DCBLV7H SNX-2112 Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [4]
Estramustine + SNX-2112 DCAGN5S SNX-2112 Prostate carcinoma (Cell Line: VCAP) [4]
Estramustine + Terameprocol DCUFW4U Terameprocol Non-small cell lung carcinoma (Cell Line: HOP-92) [4]
Estramustine + SCH 727965 DCEDSWI SCH 727965 Adenocarcinoma (Cell Line: CAOV3) [4]
Estramustine + SCH 727965 DCBJNYB SCH 727965 Adenocarcinoma (Cell Line: OVCAR3) [4]
Estramustine + SCH 727965 DC8LG30 SCH 727965 Adenocarcinoma (Cell Line: A427) [4]
Estramustine + SCH 727965 DCSJ2X0 SCH 727965 Adenocarcinoma (Cell Line: NCIH2122) [4]
Estramustine + SCH 727965 DCLA6Q6 SCH 727965 Adenocarcinoma (Cell Line: NCIH520) [4]
Estramustine + SCH 727965 DCFUSYF SCH 727965 Adenocarcinoma (Cell Line: HT29) [4]
Estramustine + SCH 727965 DCFHVZY SCH 727965 Adenocarcinoma (Cell Line: SW-620) [4]
Estramustine + SCH 727965 DC69O7A SCH 727965 Amelanotic melanoma (Cell Line: A2058) [4]
Estramustine + SCH 727965 DC7J14Z SCH 727965 Large cell lung carcinoma (Cell Line: NCI-H460) [4]
Estramustine + SCH 727965 DC7JIS4 SCH 727965 Malignant melanoma (Cell Line: A375) [4]
Estramustine + SCH 727965 DCVV960 SCH 727965 Malignant melanoma (Cell Line: HT144) [4]
Estramustine + SCH 727965 DCWXMJA SCH 727965 Malignant melanoma (Cell Line: RPMI7951) [4]
Estramustine + SCH 727965 DCCYZOB SCH 727965 Malignant melanoma (Cell Line: UACC62) [4]
Estramustine + SCH 727965 DCA3GPR SCH 727965 Mesothelioma (Cell Line: MSTO) [4]
Estramustine + SCH 727965 DCJVNL9 SCH 727965 Non small cell carcinoma (Cell Line: SKMES1) [4]
Estramustine + SCH 727965 DC3LHTQ SCH 727965 Ovarian endometrioid adenocarcinoma (Cell Line: A2780) [4]
Estramustine + Erlotinib DC09RVN Erlotinib Adenocarcinoma (Cell Line: OVCAR3) [4]
Estramustine + Erlotinib DCNUD6B Erlotinib Adenocarcinoma (Cell Line: NCIH2122) [4]
Estramustine + Erlotinib DCTVHIA Erlotinib Adenocarcinoma (Cell Line: COLO320DM) [4]
Estramustine + Erlotinib DCAODRI Erlotinib Adenocarcinoma (Cell Line: HT29) [4]
Estramustine + Erlotinib DC0WVH4 Erlotinib Adenocarcinoma (Cell Line: SW-620) [4]
Estramustine + Erlotinib DC0TU8K Erlotinib Amelanotic melanoma (Cell Line: A2058) [4]
Estramustine + Erlotinib DCFSS8I Erlotinib Large cell lung carcinoma (Cell Line: NCI-H460) [4]
Estramustine + Erlotinib DCRGM44 Erlotinib Malignant melanoma (Cell Line: A375) [4]
Estramustine + Erlotinib DC2PCL9 Erlotinib Malignant melanoma (Cell Line: HT144) [4]
Estramustine + Erlotinib DCN2962 Erlotinib Malignant melanoma (Cell Line: RPMI7951) [4]
Estramustine + Erlotinib DC1EM91 Erlotinib Malignant melanoma (Cell Line: UACC62) [4]
Estramustine + Erlotinib DCVS3W2 Erlotinib Mesothelioma (Cell Line: MSTO) [4]
Estramustine + Erlotinib DCXJB7E Erlotinib Non small cell carcinoma (Cell Line: SKMES1) [4]
Estramustine + Erlotinib DCKQ987 Erlotinib Ovarian endometrioid adenocarcinoma (Cell Line: A2780) [4]
Estramustine + Erlotinib DCI0N3D Erlotinib Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [4]
Estramustine + Erlotinib DCMGXD5 Erlotinib Prostate carcinoma (Cell Line: LNCAP) [4]
Estramustine + Erlotinib DC7HOPS Erlotinib Prostate carcinoma (Cell Line: VCAP) [4]
Estramustine + Ifosfamide DC6RK4Z Ifosfamide Lung adenocarcinoma (Cell Line: MDA-MB-231) [4]
Estramustine + Ifosfamide DCHS51B Ifosfamide Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [4]
Estramustine + Docetaxel DCHM2Z4 Docetaxel Adenocarcinoma (Cell Line: NCIH23) [4]
Estramustine + Docetaxel DCFONZU Docetaxel Lung adenocarcinoma (Cell Line: MDA-MB-231) [4]
Estramustine + Raloxifene DC2057S Raloxifene Adenocarcinoma (Cell Line: A549) [4]
Estramustine + Raloxifene DC8H4VR Raloxifene Amelanotic melanoma (Cell Line: M14) [4]
Estramustine + Raloxifene DCOF6VT Raloxifene High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [4]
Estramustine + Raloxifene DCVCI00 Raloxifene Malignant melanoma (Cell Line: UACC62) [4]
Estramustine + Raloxifene DC1K2L3 Raloxifene Melanoma (Cell Line: UACC-257) [4]
Estramustine + Raloxifene DC38CP7 Raloxifene Non-small cell lung carcinoma (Cell Line: HOP-92) [4]
Estramustine + Raloxifene DCROO7R Raloxifene Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [4]
Estramustine + MK-5108 DCROSU1 MK-5108 Adenocarcinoma (Cell Line: CAOV3) [4]
Estramustine + MK-5108 DCFLH11 MK-5108 Adenocarcinoma (Cell Line: NCIH23) [4]
Estramustine + MK-5108 DCR2FV7 MK-5108 Adenocarcinoma (Cell Line: COLO320DM) [4]
Estramustine + MK-5108 DC1VTGF MK-5108 Adenocarcinoma (Cell Line: DLD1) [4]
Estramustine + MK-5108 DC2NERJ MK-5108 Adenocarcinoma (Cell Line: HT29) [4]
Estramustine + MK-5108 DCJ70UI MK-5108 Amelanotic melanoma (Cell Line: A2058) [4]
Estramustine + MK-5108 DCZTFSZ MK-5108 Germ cell tumour (Cell Line: PA1) [4]
Estramustine + MK-5108 DCGMPWJ MK-5108 Malignant melanoma (Cell Line: A375) [4]
Estramustine + MK-5108 DCD30UN MK-5108 Malignant melanoma (Cell Line: RPMI7951) [4]
Estramustine + MK-5108 DCRJN2P MK-5108 Malignant melanoma (Cell Line: SKMEL30) [4]
Estramustine + MK-5108 DC6RPZ8 MK-5108 Malignant melanoma (Cell Line: UACC62) [4]
Estramustine + MK-5108 DCZU85E MK-5108 Mesothelioma (Cell Line: MSTO) [4]
Estramustine + MK-5108 DCYIFMU MK-5108 Ovarian endometrioid adenocarcinoma (Cell Line: A2780) [4]
Estramustine + MK-5108 DCBIT89 MK-5108 Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [4]
Estramustine + Bendamustine hydrochloride DCTSBC5 Bendamustine hydrochloride Adenocarcinoma (Cell Line: HCT116) [4]
Estramustine + Bendamustine hydrochloride DCU55XM Bendamustine hydrochloride Malignant melanoma (Cell Line: LOX IMVI) [4]
Estramustine + Mitomycin DCUJ2DR Mitomycin Adenocarcinoma (Cell Line: HCC-2998) [4]
Estramustine + Mitomycin DCVM7UZ Mitomycin High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [4]
Estramustine + Mitomycin DC87JSR Mitomycin Lung adenocarcinoma (Cell Line: HOP-62) [4]
Estramustine + Altretamine DCLUQWY Altretamine Lung adenocarcinoma (Cell Line: HOP-62) [4]
Estramustine + Altretamine DCCHNII Altretamine Lung adenocarcinoma (Cell Line: NCI-H522) [4]
Estramustine + Altretamine DC2LB1G Altretamine Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [4]
Estramustine + Ridaforolimus DC3NB9F Ridaforolimus Amelanotic melanoma (Cell Line: A2058) [4]
Estramustine + Ridaforolimus DC01IYE Ridaforolimus Malignant melanoma (Cell Line: RPMI7951) [4]
Estramustine + Ridaforolimus DCBQ6A5 Ridaforolimus Ovarian endometrioid adenocarcinoma (Cell Line: A2780) [4]
Estramustine + Ridaforolimus DCZ9BR2 Ridaforolimus Prostate carcinoma (Cell Line: LNCAP) [4]
Estramustine + TEM DCHPXZP TEM Adenocarcinoma (Cell Line: DU-145) [4]
Estramustine + MK-4827 DCFQCRE MK-4827 Adenocarcinoma (Cell Line: CAOV3) [4]
Estramustine + MK-4827 DC5B0CG MK-4827 Adenocarcinoma (Cell Line: A427) [4]
Estramustine + MK-4827 DCGOSKE MK-4827 Adenocarcinoma (Cell Line: NCIH1650) [4]
Estramustine + MK-4827 DCXQNEO MK-4827 Adenocarcinoma (Cell Line: NCIH2122) [4]
Estramustine + MK-4827 DC9PTV3 MK-4827 Adenocarcinoma (Cell Line: NCIH23) [4]
Estramustine + MK-4827 DCWEHI9 MK-4827 Adenocarcinoma (Cell Line: NCIH520) [4]
Estramustine + MK-4827 DC3WP0U MK-4827 Adenocarcinoma (Cell Line: COLO320DM) [4]
Estramustine + MK-4827 DCMEYC8 MK-4827 Adenocarcinoma (Cell Line: DLD1) [4]
Estramustine + MK-4827 DCSUO6D MK-4827 Adenocarcinoma (Cell Line: HCT116) [4]
Estramustine + MK-4827 DCEJDAW MK-4827 Adenocarcinoma (Cell Line: HT29) [4]
Estramustine + MK-4827 DCNCC3T MK-4827 Adenocarcinoma (Cell Line: SW-620) [4]
Estramustine + MK-4827 DC3CSQQ MK-4827 Amelanotic melanoma (Cell Line: A2058) [4]
Estramustine + MK-4827 DC4R6GG MK-4827 Germ cell tumour (Cell Line: PA1) [4]
Estramustine + MK-4827 DCFNRK6 MK-4827 Large cell lung carcinoma (Cell Line: NCI-H460) [4]
Estramustine + MK-4827 DCPS87M MK-4827 Malignant melanoma (Cell Line: A375) [4]
Estramustine + MK-4827 DC806PV MK-4827 Malignant melanoma (Cell Line: RPMI7951) [4]
Estramustine + MK-4827 DCURHSP MK-4827 Malignant melanoma (Cell Line: SKMEL30) [4]
Estramustine + MK-4827 DC8KZKY MK-4827 Malignant melanoma (Cell Line: UACC62) [4]
Estramustine + MK-4827 DCRQ1ZE MK-4827 Mesothelioma (Cell Line: MSTO) [4]
Estramustine + MK-4827 DC3QHQH MK-4827 Non small cell carcinoma (Cell Line: SKMES1) [4]
Estramustine + MK-4827 DCB5BI2 MK-4827 Ovarian endometrioid adenocarcinoma (Cell Line: A2780) [4]
Estramustine + MK-4827 DC2EAWX MK-4827 Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [4]
Estramustine + MK-4827 DC1VSSS MK-4827 Prostate carcinoma (Cell Line: LNCAP) [4]
Estramustine + MK-4827 DCN438M MK-4827 Prostate carcinoma (Cell Line: VCAP) [4]
Estramustine + Idarubicin DCBDOSY Idarubicin Adenocarcinoma (Cell Line: COLO320DM) [4]
Estramustine + Idarubicin DCHB0XM Idarubicin Adenocarcinoma (Cell Line: HT29) [4]
Estramustine + Idarubicin DC0K9PN Idarubicin High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [4]
Estramustine + Idarubicin DC4P7OI Idarubicin Lung adenocarcinoma (Cell Line: MDA-MB-231) [4]
Estramustine + Idarubicin DCNQNLZ Idarubicin Malignant melanoma (Cell Line: RPMI7951) [4]
Estramustine + Idarubicin DCUD52V Idarubicin Mesothelioma (Cell Line: MSTO) [4]
Estramustine + Idarubicin DCVUMXN Idarubicin Ovarian endometrioid adenocarcinoma (Cell Line: A2780) [4]
Estramustine + Idarubicin DCS8VOP Idarubicin Prostate carcinoma (Cell Line: VCAP) [4]
Estramustine + Bortezomib DCISVTS Bortezomib Adenocarcinoma (Cell Line: COLO320DM) [4]
Estramustine + Bortezomib DC9E9NJ Bortezomib Adenocarcinoma (Cell Line: DLD1) [4]
Estramustine + Bortezomib DC97OHD Bortezomib Adenocarcinoma (Cell Line: SW-620) [4]
Estramustine + Bortezomib DCIO55I Bortezomib Amelanotic melanoma (Cell Line: A2058) [4]
Estramustine + Bortezomib DCI6GEU Bortezomib Large cell lung carcinoma (Cell Line: NCI-H460) [4]
Estramustine + Bortezomib DC4LZS1 Bortezomib Malignant melanoma (Cell Line: HT144) [4]
Estramustine + Bortezomib DCFSUEA Bortezomib Malignant melanoma (Cell Line: RPMI7951) [4]
Estramustine + Bortezomib DCHE1Q2 Bortezomib Malignant melanoma (Cell Line: SKMEL30) [4]
Estramustine + Bortezomib DCZHRY6 Bortezomib Malignant melanoma (Cell Line: UACC62) [4]
Estramustine + Bortezomib DC4YQYC Bortezomib Mesothelioma (Cell Line: MSTO) [4]
Estramustine + Bortezomib DCE4P45 Bortezomib Ovarian endometrioid adenocarcinoma (Cell Line: A2780) [4]
Estramustine + GSK525762 DCA35HV GSK525762 Adenocarcinoma (Cell Line: NCIH2122) [4]
Estramustine + GSK525762 DC9QO9X GSK525762 Adenocarcinoma (Cell Line: NCIH23) [4]
Estramustine + GSK525762 DCLJ4OU GSK525762 Adenocarcinoma (Cell Line: COLO320DM) [4]
Estramustine + GSK525762 DC8ZS1S GSK525762 Adenocarcinoma (Cell Line: DLD1) [4]
Estramustine + GSK525762 DCWDSFA GSK525762 Adenocarcinoma (Cell Line: HCT116) [4]
Estramustine + GSK525762 DC3V4H5 GSK525762 Adenocarcinoma (Cell Line: SW-620) [4]
Estramustine + GSK525762 DC07ECV GSK525762 Amelanotic melanoma (Cell Line: A2058) [4]
Estramustine + GSK525762 DCRF32H GSK525762 Malignant melanoma (Cell Line: A375) [4]
Estramustine + GSK525762 DCGWT2C GSK525762 Malignant melanoma (Cell Line: SKMEL30) [4]
Estramustine + GSK525762 DCFRJSK GSK525762 Malignant melanoma (Cell Line: UACC62) [4]
Estramustine + GSK525762 DCFMMEG GSK525762 Mesothelioma (Cell Line: MSTO) [4]
Estramustine + GSK525762 DCA2HVD GSK525762 Ovarian endometrioid adenocarcinoma (Cell Line: A2780) [4]
Estramustine + GSK525762 DCB108F GSK525762 Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [4]
Estramustine + GSK525762 DC3908F GSK525762 Prostate carcinoma (Cell Line: VCAP) [4]
Estramustine + Cisplatin DCIFQNM Cisplatin Adenocarcinoma (Cell Line: HCT116) [4]
Estramustine + Chlorambucil DCJCSS9 Chlorambucil Adenocarcinoma (Cell Line: HCC-2998) [4]
Estramustine + Chlorambucil DC3VDT9 Chlorambucil Adenocarcinoma (Cell Line: HT29) [4]
Estramustine + Chlorambucil DCLFIAK Chlorambucil Non-small cell lung carcinoma (Cell Line: HOP-92) [4]
Estramustine + Sorafenib DC3MSK9 Sorafenib Mesothelioma (Cell Line: MSTO) [4]
Estramustine + ER819762 DCMQIZM ER819762 Adenocarcinoma (Cell Line: OVCAR3) [4]
Estramustine + ER819762 DCS96IZ ER819762 Adenocarcinoma (Cell Line: HCC-2998) [4]
Estramustine + ER819762 DCCRKMV ER819762 High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4) [4]
Estramustine + ER819762 DCKCGSQ ER819762 Melanoma (Cell Line: MALME-3M) [4]
Estramustine + MK-2206 DCJK8Q2 MK-2206 Adenocarcinoma (Cell Line: CAOV3) [4]
Estramustine + MK-2206 DCWKQPN MK-2206 Adenocarcinoma (Cell Line: A427) [4]
Estramustine + MK-2206 DCY6YVA MK-2206 Adenocarcinoma (Cell Line: HCT116) [4]
Estramustine + MK-2206 DCW4WHS MK-2206 Adenocarcinoma (Cell Line: HT29) [4]
Estramustine + MK-2206 DCB9TCN MK-2206 Adenocarcinoma (Cell Line: SW-620) [4]
Estramustine + MK-2206 DC2QJTT MK-2206 Amelanotic melanoma (Cell Line: A2058) [4]
Estramustine + MK-2206 DCQ3LJY MK-2206 Germ cell tumour (Cell Line: PA1) [4]
Estramustine + MK-2206 DC5BFHA MK-2206 Large cell lung carcinoma (Cell Line: NCI-H460) [4]
Estramustine + MK-2206 DCF1QQ0 MK-2206 Malignant melanoma (Cell Line: A375) [4]
Estramustine + MK-2206 DC6ULTO MK-2206 Malignant melanoma (Cell Line: HT144) [4]
Estramustine + MK-2206 DCYR7D4 MK-2206 Malignant melanoma (Cell Line: RPMI7951) [4]
Estramustine + MK-2206 DCD96Y6 MK-2206 Malignant melanoma (Cell Line: SKMEL30) [4]
Estramustine + MK-2206 DCH9ZH2 MK-2206 Malignant melanoma (Cell Line: UACC62) [4]
Estramustine + MK-2206 DCIJJ1U MK-2206 Mesothelioma (Cell Line: MSTO) [4]
Estramustine + MK-2206 DCT74DR MK-2206 Ovarian endometrioid adenocarcinoma (Cell Line: A2780) [4]
Estramustine + Romidepsin DCPEDS3 Romidepsin Adenocarcinoma (Cell Line: NCIH23) [4]
Estramustine + Azacitidine DC3VT2N Azacitidine Adenocarcinoma (Cell Line: HT29) [4]
Estramustine + Azacitidine DCNC6I0 Azacitidine Large cell lung carcinoma (Cell Line: NCI-H460) [4]
Estramustine + Pomalidomide DCJQ3DP Pomalidomide Adenocarcinoma (Cell Line: OVCAR3) [4]
Estramustine + Pomalidomide DCNEM58 Pomalidomide Lung adenocarcinoma (Cell Line: HOP-62) [4]
Estramustine + Pomalidomide DC9C68W Pomalidomide Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [4]
Estramustine + Mercaptopurine DCRXVAT Mercaptopurine Melanoma (Cell Line: SK-MEL-2) [4]
Estramustine + Mepacrine DCPGLMJ Mepacrine Adenocarcinoma (Cell Line: OVCAR3) [4]
Estramustine + Mepacrine DCO7QWE Mepacrine Adenocarcinoma (Cell Line: SW-620) [4]
Estramustine + Mepacrine DCQPNAT Mepacrine Adenocarcinoma (Cell Line: HCT116) [4]
Estramustine + Mepacrine DCDJN9W Mepacrine High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [4]
Estramustine + Mepacrine DCZWKDR Mepacrine High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [4]
Estramustine + Mepacrine DCR889E Mepacrine Melanoma (Cell Line: SK-MEL-2) [4]
Estramustine + PMID28870136-Compound-43 DCF6E51 PMID28870136-Compound-43 Adenocarcinoma (Cell Line: SW-620) [4]
Estramustine + PMID28870136-Compound-43 DCB6SZR PMID28870136-Compound-43 Lung adenocarcinoma (Cell Line: MDA-MB-231) [4]
Estramustine + PMID28870136-Compound-43 DC7GLWM PMID28870136-Compound-43 Lung adenocarcinoma (Cell Line: NCI-H522) [4]
Estramustine + FORMESTANE DCC5T5D FORMESTANE Cutaneous melanoma (Cell Line: SK-MEL-5) [4]
Estramustine + FORMESTANE DC461Y6 FORMESTANE Malignant melanoma (Cell Line: LOX IMVI) [4]
Estramustine + Aminolevulinic Acid Hydrochloride DCAG39G Aminolevulinic Acid Hydrochloride Adenocarcinoma (Cell Line: OVCAR3) [4]
Estramustine + Aminolevulinic Acid Hydrochloride DCNDLEH Aminolevulinic Acid Hydrochloride Adenocarcinoma (Cell Line: A549) [4]
Estramustine + Aminolevulinic Acid Hydrochloride DCIZBFU Aminolevulinic Acid Hydrochloride Large cell lung carcinoma (Cell Line: NCI-H460) [4]
Estramustine + Aminolevulinic Acid Hydrochloride DCXDHZW Aminolevulinic Acid Hydrochloride Malignant melanoma (Cell Line: LOX IMVI) [4]
Estramustine + Busulfan DC672CD Busulfan Lung adenocarcinoma (Cell Line: MDA-MB-231) [4]
Estramustine + Dasatinib DCS1KXW Dasatinib Adenocarcinoma (Cell Line: CAOV3) [4]
Estramustine + Dasatinib DCRVBEL Dasatinib Adenocarcinoma (Cell Line: OVCAR3) [4]
Estramustine + Dasatinib DCY0R1C Dasatinib Adenocarcinoma (Cell Line: A427) [4]
Estramustine + Dasatinib DCM3M68 Dasatinib Adenocarcinoma (Cell Line: NCIH23) [4]
Estramustine + Dasatinib DCKGOPS Dasatinib Adenocarcinoma (Cell Line: NCIH520) [4]
Estramustine + Dasatinib DCUFG20 Dasatinib Amelanotic melanoma (Cell Line: A2058) [4]
Estramustine + Dasatinib DCCXCA5 Dasatinib Germ cell tumour (Cell Line: PA1) [4]
Estramustine + Dasatinib DCFPZ5T Dasatinib High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [4]
Estramustine + Dasatinib DC3FL79 Dasatinib Large cell lung carcinoma (Cell Line: NCI-H460) [4]
Estramustine + Dasatinib DCPYYO0 Dasatinib Malignant melanoma (Cell Line: A375) [4]
Estramustine + Dasatinib DCZGYAV Dasatinib Malignant melanoma (Cell Line: SKMEL30) [4]
Estramustine + Dasatinib DC5NBBO Dasatinib Mesothelioma (Cell Line: MSTO) [4]
Estramustine + Dasatinib DCB5DFX Dasatinib Non small cell carcinoma (Cell Line: SKMES1) [4]
Estramustine + Dasatinib DCT3GH5 Dasatinib Non-small cell lung carcinoma (Cell Line: HOP-92) [4]
Estramustine + Dasatinib DCZXKUI Dasatinib Ovarian endometrioid adenocarcinoma (Cell Line: A2780) [4]
Estramustine + Dasatinib DC8N67L Dasatinib Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [4]
Estramustine + Dasatinib DCTK4D2 Dasatinib Prostate carcinoma (Cell Line: VCAP) [4]
Ethambutol + Estramustine DCDA0K5 Ethambutol Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Ethinyl estradiol + Estramustine DCTLXAV Ethinyl estradiol Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Ezetimibe + Estramustine DCS4BFD Ezetimibe Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Fenoprofen + Estramustine DCGO04P Fenoprofen Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Fludarabine + Estramustine DCKMS3G Fludarabine Anaplastic large cell lymphoma (Cell Line: SR) [2]
Fludarabine + Estramustine DCX694Y Fludarabine Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [2]
Fluorouracil + Estramustine DC6EJAY Fluorouracil Ewing sarcoma-peripheral primitive neuroectodermal tumour (Cell Line: ES2) [2]
Fluorouracil + Estramustine DC3391I Fluorouracil Breast and ovarian cancer syndrome (Cell Line: UWB1289) [3]
Fluorouracil + Estramustine DCQEYCI Fluorouracil Breast carcinoma (Cell Line: OCUBM) [3]
Fluorouracil + Estramustine DC45OUK Fluorouracil Rectal adenocarcinoma (Cell Line: SW837) [3]
Fluorouracil + Estramustine DCNMZTZ Fluorouracil Adenocarcinoma (Cell Line: A427) [4]
Fluorouracil + Estramustine DCQAC7B Fluorouracil Adenocarcinoma (Cell Line: NCIH23) [4]
Fluorouracil + Estramustine DC1HNM3 Fluorouracil Adenocarcinoma (Cell Line: COLO320DM) [4]
Fluorouracil + Estramustine DCKS94D Fluorouracil Amelanotic melanoma (Cell Line: A2058) [4]
Fluorouracil + Estramustine DCEXSZU Fluorouracil Germ cell tumour (Cell Line: PA1) [4]
Fluorouracil + Estramustine DCDL0QH Fluorouracil Malignant melanoma (Cell Line: A375) [4]
Fluorouracil + Estramustine DCLG5ZV Fluorouracil Malignant melanoma (Cell Line: SKMEL30) [4]
Fluorouracil + Estramustine DCQ1IC9 Fluorouracil Malignant melanoma (Cell Line: UACC62) [4]
Fluorouracil + Estramustine DCQOS6W Fluorouracil Mesothelioma (Cell Line: MSTO) [4]
Fluorouracil + Estramustine DCHKTGK Fluorouracil Ovarian endometrioid adenocarcinoma (Cell Line: A2780) [4]
Fluorouracil + Estramustine DCN500T Fluorouracil Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [4]
Fomepizole + Estramustine DCH5RBO Fomepizole Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Fosfomycin + Estramustine DCLFMP2 Fosfomycin Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Furazolidone + Estramustine DC822HG Furazolidone Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Gefitinib + Estramustine DCCCCXW Gefitinib Adenocarcinoma (Cell Line: HT29) [2]
Gefitinib + Estramustine DC4AOPY Gefitinib Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [2]
Gefitinib + Estramustine DCOLTAN Gefitinib Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [2]
Ginsenoside Rb1 + Estramustine DCLJF1G Ginsenoside Rb1 Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
GS4071 + Estramustine DC509ZP GS4071 Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Hyodeoxycholic acid + Estramustine DCKAP3O Hyodeoxycholic acid Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Imatinib + Estramustine DCPQG6F Imatinib Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Indazole derivative 5 + Estramustine DCLC8BF Indazole derivative 5 Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [2]
Indazole derivative 5 + Estramustine DCXG41K Indazole derivative 5 Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [2]
Indazole derivative 5 + Estramustine DCQPS6B Indazole derivative 5 Anaplastic large cell lymphoma (Cell Line: SR) [2]
Indazole derivative 5 + Estramustine DCNZ6EV Indazole derivative 5 Astrocytoma (Cell Line: U251) [2]
Indazole derivative 5 + Estramustine DCZUDJK Indazole derivative 5 Clear cell renal cell carcinoma (Cell Line: 786-0) [2]
Indazole derivative 5 + Estramustine DCT80CT Indazole derivative 5 Glioma (Cell Line: SF-268) [2]
Indazole derivative 5 + Estramustine DC1CSVY Indazole derivative 5 Papillary renal cell carcinoma (Cell Line: ACHN) [2]
Indazole derivative 5 + Estramustine DC3F4SC Indazole derivative 5 Plasma cell myeloma (Cell Line: RPMI-8226) [2]
Indazole derivative 5 + Estramustine DCV001L Indazole derivative 5 Renal cell carcinoma (Cell Line: UO-31) [2]
Indazole derivative 5 + Estramustine DCHB54N Indazole derivative 5 Carcinoma (Cell Line: RXF 393) [3]
Indazole derivative 5 + Estramustine DC6YA5I Indazole derivative 5 Invasive ductal carcinoma (Cell Line: T-47D) [3]
Indazole derivative 5 + Estramustine DCW0NXL Indazole derivative 5 Adenocarcinoma (Cell Line: DU-145) [4]
Indazole derivative 5 + Estramustine DCGPPVP Indazole derivative 5 Adenocarcinoma (Cell Line: NCIH23) [4]
Indazole derivative 5 + Estramustine DC2W91P Indazole derivative 5 Amelanotic melanoma (Cell Line: MDA-MB-435) [4]
Indazole derivative 5 + Estramustine DC53RD4 Indazole derivative 5 High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [4]
Indazole derivative 5 + Estramustine DCGJNWU Indazole derivative 5 Large cell lung carcinoma (Cell Line: NCI-H460) [4]
Indazole derivative 5 + Estramustine DCK45JK Indazole derivative 5 Lung adenocarcinoma (Cell Line: HOP-62) [4]
JZL195 + Estramustine DC2G3A2 JZL195 Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Kanamycin + Estramustine DCS3U5X Kanamycin Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Lenalidomide + Estramustine DCAF9V1 Lenalidomide Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [4]
Letrozole + Estramustine DC5TE97 Letrozole Adenocarcinoma (Cell Line: SW-620) [2]
Letrozole + Estramustine DCEPM0W Letrozole Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [2]
Letrozole + Estramustine DCE96HM Letrozole High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [2]
Letrozole + Estramustine DCJ79OL Letrozole Lung adenocarcinoma (Cell Line: EKVX) [2]
Letrozole + Estramustine DC64H7E Letrozole Breast adenocarcinoma (Cell Line: MDA-MB-468) [3]
Levamisole + Estramustine DCOP6EP Levamisole Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
LIAROZOLE + Estramustine DC053JV LIAROZOLE Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [2]
LIAROZOLE + Estramustine DCBU065 LIAROZOLE Anaplastic large cell lymphoma (Cell Line: SR) [2]
LIAROZOLE + Estramustine DCRUKQ1 LIAROZOLE Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
LIAROZOLE + Estramustine DCXL8PH LIAROZOLE Adenocarcinoma (Cell Line: OVCAR3) [4]
Lithium Citrate + Estramustine DCBJYNX Lithium Citrate Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Mebendazole + Estramustine DCQXINI Mebendazole Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Mechlorethamine + Estramustine DCWAON1 Mechlorethamine Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [2]
Mechlorethamine + Estramustine DCKSJRC Mechlorethamine Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [4]
Memantine + Estramustine DCS8JHB Memantine Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Methylergonovine + Estramustine DCPHM0E Methylergonovine Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Metyrosine + Estramustine DC651MM Metyrosine Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Miconazole + Estramustine DCIXHBY Miconazole Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Mycophenolic acid + Estramustine DC9IXRV Mycophenolic acid Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Nabilone + Estramustine DCJEPZW Nabilone Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Nitisinone + Estramustine DCLIQMN Nitisinone Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Olmesartan medoxomil + Estramustine DCICPPF Olmesartan medoxomil Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Pentostatin + Estramustine DC9C0N1 Pentostatin Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Pepstatin + Estramustine DCY3WQC Pepstatin Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Picoplatin + Estramustine DCJSWMU Picoplatin Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [4]
Pinacidil + Estramustine DC33BVW Pinacidil Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Pomalidomide + Estramustine DCMSIBV Pomalidomide Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Pyrazinamide + Estramustine DC1PJNR Pyrazinamide Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Raloxifene + Estramustine DC1FRDA Raloxifene Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [2]
Raloxifene + Estramustine DC8YI17 Raloxifene Astrocytoma (Cell Line: SNB-19) [2]
Raloxifene + Estramustine DCAP3RV Raloxifene Clear cell renal cell carcinoma (Cell Line: 786-0) [2]
Raloxifene + Estramustine DC2CIMU Raloxifene Glioma (Cell Line: SF-268) [2]
Raloxifene + Estramustine DC3QR83 Raloxifene Glioma (Cell Line: SF-295) [2]
Raloxifene + Estramustine DC74B30 Raloxifene Carcinoma (Cell Line: RXF 393) [3]
Raloxifene + Estramustine DCXQTM2 Raloxifene Adenocarcinoma (Cell Line: DU-145) [4]
Raloxifene + Estramustine DC7IJC6 Raloxifene Adenocarcinoma (Cell Line: OVCAR3) [4]
Raloxifene + Estramustine DCL3IAM Raloxifene Adenocarcinoma (Cell Line: NCIH23) [4]
Raloxifene + Estramustine DCTL2FL Raloxifene Amelanotic melanoma (Cell Line: M14) [4]
Raloxifene + Estramustine DCDGURV Raloxifene Cutaneous melanoma (Cell Line: SK-MEL-28) [4]
Raloxifene + Estramustine DCQGH82 Raloxifene Melanoma (Cell Line: UACC-257) [4]
Raloxifene + Estramustine DCIIFU2 Raloxifene Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [4]
Repaglinide + Estramustine DCEY702 Repaglinide Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Ruxolitinib + Estramustine DCR1W0G Ruxolitinib Astrocytoma (Cell Line: SNB-19) [2]
Ruxolitinib + Estramustine DCCAN5E Ruxolitinib Invasive ductal carcinoma (Cell Line: T-47D) [3]
Ruxolitinib + Estramustine DC7Q9BN Ruxolitinib Amelanotic melanoma (Cell Line: MDA-MB-435) [4]
Sitagliptin + Estramustine DCTC3I4 Sitagliptin Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
SY-1425 + Estramustine DCIAIFB SY-1425 Melanoma (Cell Line: MALME-3M) [4]
Tamoxifen + Estramustine DCW2YEB Tamoxifen Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Tetracycline + Estramustine DCQ0Z4Z Tetracycline Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Thioguanine + Estramustine DCKR4G9 Thioguanine Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [2]
Thioguanine + Estramustine DCWJ3EG Thioguanine Chronic myelogenous leukemia (Cell Line: K-562) [2]
Thioguanine + Estramustine DCHNIAX Thioguanine Adenocarcinoma (Cell Line: OVCAR3) [4]
Thioguanine + Estramustine DCXRL8J Thioguanine Adenocarcinoma (Cell Line: NCIH23) [4]
Thioguanine + Estramustine DCUAHNB Thioguanine Adenocarcinoma (Cell Line: A549) [4]
Tiagabine + Estramustine DC7XHX9 Tiagabine Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Tolazoline + Estramustine DCLPP2S Tolazoline Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Tolvaptan + Estramustine DCF98B0 Tolvaptan Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Topotecan + Estramustine DCZG5L8 Topotecan Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [4]
Topotecan + Estramustine DCKIVSW Topotecan Clear cell renal cell carcinoma (Cell Line: CAKI-1) [4]
Topotecan + Estramustine DC8BUUO Topotecan Cutaneous melanoma (Cell Line: SK-MEL-28) [4]
Topotecan + Estramustine DC5EJRJ Topotecan Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [4]
Topotecan + Estramustine DCNLDCK Topotecan Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [4]
Topotecan + Estramustine DCGR9UT Topotecan Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [4]
Triapine + Estramustine DCMLS4W Triapine Chronic myelogenous leukemia (Cell Line: KBM-7) [4]
Trifluridine + Estramustine DCSKDFL Trifluridine Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [2]
Trifluridine + Estramustine DCL14JJ Trifluridine Anaplastic large cell lymphoma (Cell Line: SR) [2]
Trifluridine + Estramustine DC1GDUM Trifluridine Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [2]
Trifluridine + Estramustine DCT39BZ Trifluridine High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [4]
Trifluridine + Estramustine DCLXTJS Trifluridine Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [4]
Trihexyphenidyl + Estramustine DCMGKJE Trihexyphenidyl Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Uracil mustard + Estramustine DCKNE5Q Uracil mustard Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [2]
Uracil mustard + Estramustine DCPVMEB Uracil mustard Adenocarcinoma (Cell Line: NCIH23) [4]
Vandetanib + Estramustine DC94MPY Vandetanib Breast adenocarcinoma (Cell Line: MDA-MB-468) [3]
Vandetanib + Estramustine DC1T5R1 Vandetanib Colon adenocarcinoma (Cell Line: COLO 205) [3]
Vandetanib + Estramustine DCC3OQA Vandetanib Invasive ductal carcinoma (Cell Line: HS 578T) [3]
Vandetanib + Estramustine DC3OTLI Vandetanib Adenocarcinoma (Cell Line: HCC-2998) [4]
Vandetanib + Estramustine DCOXLDW Vandetanib Adenocarcinoma (Cell Line: HCT116) [4]
Vandetanib + Estramustine DCD282M Vandetanib Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [4]
Vandetanib + Estramustine DCCV0ZG Vandetanib Amelanotic melanoma (Cell Line: MDA-MB-435) [4]
Vandetanib + Estramustine DC4HAKY Vandetanib Anaplastic large cell lymphoma (Cell Line: SR) [4]
Vandetanib + Estramustine DCLAZXW Vandetanib Astrocytoma (Cell Line: SNB-19) [4]
Vandetanib + Estramustine DCU5RJ2 Vandetanib Cutaneous melanoma (Cell Line: SK-MEL-28) [4]
Vandetanib + Estramustine DCAA1BJ Vandetanib Glioma (Cell Line: SF-268) [4]
Vandetanib + Estramustine DCHNO8T Vandetanib Large cell lung carcinoma (Cell Line: NCI-H460) [4]
Vandetanib + Estramustine DC8ETU5 Vandetanib Malignant melanoma (Cell Line: LOX IMVI) [4]
Vandetanib + Estramustine DC3DI5Z Vandetanib Melanoma (Cell Line: SK-MEL-2) [4]
Vandetanib + Estramustine DCEBV1D Vandetanib Non-small cell lung carcinoma (Cell Line: HOP-92) [4]
Vandetanib + Estramustine DC86089 Vandetanib Plasma cell myeloma (Cell Line: RPMI-8226) [4]
Vemurafenib + Estramustine DCI5PVZ Vemurafenib Breast adenocarcinoma (Cell Line: MDA-MB-468) [3]
Vemurafenib + Estramustine DCIJMK0 Vemurafenib Invasive ductal carcinoma (Cell Line: HS 578T) [3]
Vemurafenib + Estramustine DCUPXGC Vemurafenib Invasive ductal carcinoma (Cell Line: BT-549) [3]
Vemurafenib + Estramustine DC0PPCF Vemurafenib Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [4]
Vemurafenib + Estramustine DC6IFFO Vemurafenib Anaplastic large cell lymphoma (Cell Line: SR) [4]
Vemurafenib + Estramustine DCWGRM6 Vemurafenib Astrocytoma (Cell Line: SNB-19) [4]
Vemurafenib + Estramustine DCEAB6Y Vemurafenib Clear cell renal cell carcinoma (Cell Line: A498) [4]
Vemurafenib + Estramustine DCF086C Vemurafenib Clear cell renal cell carcinoma (Cell Line: 786-0) [4]
Vemurafenib + Estramustine DC8AJB0 Vemurafenib Cutaneous melanoma (Cell Line: SK-MEL-5) [4]
Vemurafenib + Estramustine DCX63PE Vemurafenib High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [4]
Vemurafenib + Estramustine DC1ONYY Vemurafenib High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [4]
Vemurafenib + Estramustine DC4PPHQ Vemurafenib Melanoma (Cell Line: UACC-257) [4]
Vemurafenib + Estramustine DCEYPOR Vemurafenib Renal cell carcinoma (Cell Line: UO-31) [4]
Vincristine + Estramustine DCNRRYO Vincristine Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [2]
Vincristine + Estramustine DCKVDRT Vincristine Lung adenocarcinoma (Cell Line: HOP-62) [2]
Vismodegib + Estramustine DCSC7DJ Vismodegib Carcinoma (Cell Line: RXF 393) [3]
Vismodegib + Estramustine DCR5E64 Vismodegib Adenocarcinoma (Cell Line: DU-145) [4]
Vismodegib + Estramustine DC1XXHE Vismodegib Clear cell renal cell carcinoma (Cell Line: 786-0) [4]
Vismodegib + Estramustine DC0G52X Vismodegib Malignant melanoma (Cell Line: LOX IMVI) [4]
------------------------------------------------------------------------------------
⏷ Show the Full List of 858 DrugCom(s)
3 Clinical Trial Drug Combination(s) Consisting of This drug
DrugCom Name DrugCom ID Component Drug Indication REF
Docetaxel + Estramustine DCN6FU5 Docetaxel Prostate Cancer [5]
Paclitaxel + Estramustine DC2MVWS Paclitaxel Prostate Cancer [6]
Vinorelbine + Estramustine DC1PQR3 Vinorelbine Prostate Cancer [7]
------------------------------------------------------------------------------------

References

1 Natural products as sources of new drugs over the last 25 years. J Nat Prod. 2007 Mar;70(3):461-77.
2 Recurrent recessive mutation in deoxyguanosine kinase causes idiopathic noncirrhotic portal hypertension.Hepatology. 2016 Jun;63(6):1977-86. doi: 10.1002/hep.28499. Epub 2016 Mar 31.
3 Biologically active neutrophil chemokine pattern in tonsillitis.Clin Exp Immunol. 2004 Mar;135(3):511-8. doi: 10.1111/j.1365-2249.2003.02390.x.
4 Loss of function mutations in VARS encoding cytoplasmic valyl-tRNA synthetase cause microcephaly, seizures, and progressive cerebral atrophy.Hum Genet. 2018 Apr;137(4):293-303. doi: 10.1007/s00439-018-1882-3. Epub 2018 Apr 24.
5 ClinicalTrials.gov (NCT00004001) S9916, Combination Therapy in Treating Patients With Advanced Prostate Cancer That Has Not Responded to Hormone Therapy
6 ClinicalTrials.gov (NCT00038168) Intravenous Estramustine With Taxol in Hormone Refractory Prostate Adenocarcinoma
7 ClinicalTrials.gov (NCT00151086) Oral Estramustine and Oral Vinorelbine in the Treatment of Hormone-Refractory Prostate Cancer